Next Article in Journal
The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening
Next Article in Special Issue
Clitorienolactones and Isoflavonoids of Clitorea ternatea Roots Alleviate Stress-Like Symptoms in a Reserpine-Induced Zebrafish Model
Previous Article in Journal
Aronia melanocarpa (Michx.) Elliot, Chaenomeles superba Lindl. and Cornus mas L. Leaf Extracts as Natural Preservatives for Pork Meat Products
Previous Article in Special Issue
Validated Stability-Indicating GC-MS Method for Characterization of Forced Degradation Products of Trans-Caffeic Acid and Trans-Ferulic Acid
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential

School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India
National Institute for Agricultural and Veterinary Research (INIAV), I.P., Vairão, 4485-655 Vila do Conde, Portugal
Center for Study in Animal Science (CECA), ICETA, University of Porto, 4051-401 Porto, Portugal
Scientific Consulting, Chemical Engineering, University of Chemical Technology and Metallurgy, 1734 Sofia, Bulgaria
Department of Rasashastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India
Department of Chemistry, Faculty of Science, University of Hradec Kralove, 50003 Hradec Kralove, Czech Republic
School of Bioengineering & Food Technology, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India
Biology Department, Science and Humanities College, Shaqra University, Alquwayiyah 11971, Saudi Arabia
School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India
Department of Environmental Biology, Sapienza University of Rome, Square Aldo Moro, 5, 00185 Rome, Italy
Department of Biochemistry, University of Allahabad, Allahabad 211002, India
School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India
Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal
CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Rua Central de Gandra, 1317, 4585-116 Gandra PRD, Portugal
Authors to whom correspondence should be addressed.
Molecules 2021, 26(10), 3005;
Received: 20 April 2021 / Revised: 13 May 2021 / Accepted: 14 May 2021 / Published: 18 May 2021


Conifers have long been recognized for their therapeutic potential in different disorders. Alkaloids, terpenes and polyphenols are the most abundant naturally occurring phytochemicals in these plants. Here, we provide an overview of the phytochemistry and related commercial products obtained from conifers. The pharmacological actions of different phytochemicals present in conifers against bacterial and fungal infections, cancer, diabetes and cardiovascular diseases are also reviewed. Data obtained from experimental and clinical studies performed to date clearly underline that such compounds exert promising antioxidant effects, being able to inhibit cell damage, cancer growth, inflammation and the onset of neurodegenerative diseases. Therefore, an attempt has been made with the intent to highlight the importance of conifer-derived extracts for pharmacological purposes, with the support of relevant in vitro and in vivo experimental data. In short, this review comprehends the information published to date related to conifers’ phytochemicals and illustrates their potential role as drugs.

1. Introduction

Medicinal plants have long been used as a source for traditional remedies in nearly all cultures [1]. Nature provides an endless supply of novel phytochemicals, which are referred to as natural products (NPs), and natural product drug development is a difficult task for developing new leads [2]. Traditional medicines (TMs) are valuable because they use natural products; for example, Ayurveda, Kampo, traditional Chinese medicine (TCM), traditional Korean medicine (TKM) and Unani use natural products and have been practiced for thousands of years, blossoming into well-regulated medical systems [3]. As time passed and medication progressed, synthetic drugs, such as enoxaparin, aspirin, warfarin, ibuprofen, naproxen, clopidogrel and diclofenac, became available over the counter and were linked to mild (headaches, back pain) to severe side effects (difficulty breathing, excessive bleeding, and hemorrhage) [4]. There are no doubts that the use of natural products has markedly improved certain forms of cancer, diabetes, hypertension, pain, memory deficit, Alzheimer’s disease (AD), and migraine [5], and their further use should be continued in order to meet the urgent need for effective drugs to treat human diseases [6].
Coniferous plants, such as plants belonging to the Taxus, Cupressus, Picea, Pinus, Cedrus, Araucaria genera, are found worldwide and have shown several beneficial activities against diseases, highlighting the importance of conifers in drug development [7]. Conifers are woody, have needle-shaped single-veined leaves, and consist of male and female unisexual cones with bract scales [8]. They comprise eight families (Pinaceae, Araucariaceae, Cupressaceae, Podocarpaceae, Cephalotaxaceae, Taxaceae, Phyllocladaceae, Sciadopityaceae), 70 genera, and 630 species [9]. A number of genera include a vast number of species, such as Pinus (110), Podocarpus (105), Juniperus (55), Abies (50), Picea (35), Dacrydium (21), Taxodium (29) Pseudotsuga (22), Agathis (22), Araucaria (19), and Taxus (19), whereas there are some genera which contain a lower number of species, including Larix (10), Cedrus (4), Torreya (6) and Cryptomeria (1) [10]. They can be found in abundance in tropical lowland and submontane forests (Figure 1).
They contain secondary metabolites that combat pathogens and activate the plant’s defense mechanism [12]. The three major phytochemical groups, viz. terpenoids (resin acids and terpenes), alkaloids (piperidines) and polyphenols (phenolic acids, flavonoids, proanthocyanidins, lignans, acetophenones, and stilbenes) [13], present in the species of conifer trees are shown in Table 1, and their phytochemical compounds’ structures are shown in Figure 2. It is very important to understand the evolutionary pathway of Gymnosperms, in accordance with Sporne’s proposal, wherein the conifers represent the core, and the teachings that we can receive from it, comparing the morphological characters and their correlation with the chemical ones [14].
Table 1. Phytochemical constituents present in conifers.
Table 1. Phytochemical constituents present in conifers.
SubclasssMain Examples of Each ClassConifer spp.References
Monoterpenesβ-myrcene, α-pinene, limonene, α-terpinene, thujone, camphene, β-pinene, thujole, Δ-3-carene, phellandrenePinus roxburghii, P. pinea, P. wallichiana, P. pinaster, P.sylvestris, P. gerardiana, P. nigra, P. radiata, Thuja occidentalis, Abies alba, Picea abies, Metasequoia glyptostroboides[12,15,16,17]
SesquiterpenesLaurenobiolide, farnesene, inulicin, vernodalin, 3H-benzofuaran-2-one, 4-methyl-3-methoxy-3H-benzofuaran-2-one, 4,9(α)-dihydroxynardosin-6-en, delta-cadinene, alpha-humulene, beta-cedrene, trans-caryophyllene, cubenolP. mariana, Juniperus foetidissima, A. alba, P. abies, M. glyptostroboides, J. phoenicea, P. roxburghii[8,12,18,19,20]
DiterpenesPaclitaxel, 10-deacetylbaccatin III, tasumatrol B, taxodal, sandaracopimaric acid, taxodione, xanthoperol, andrographolide, gibberellin A8, 7α-hydroxysandaracopimaric acid, gibberellin A12, gibberellin A12 aldehyde, gibberellin A15, 14α-hydroxyisopimaric acid, 12-hydroxydehydroabietic acid, gibberellin A19, gibberellin A9, carnosol, lathyrol, E-communic acid, 15-hydroxy-8(17),13(E)-labdadiene-19-carboxilic acid, holophyllin A, holophyllin D, sugiol, ferruginolTaxus brevifolia, T. baccata, T. globosa, T. distichum, P. mariana, J. taxifolia, M. glyptostroboides, A. holophylla, J. excelsa, J. communis, J. excelsa, J. communis[18,19,21,22,23,24,25,26,27]
Nitrogen Compounds
AlkaloidsVellosimine, 1,6-dehydropinidine, cis-pinidine, 1,6-dehydropinidinone, epipinidinone, cis-pinidinol, trans-pinidine, euphococcinine, α-pipecoline 1, (−)-pinidineP. mariana, P. abies, P. sabiniana, P. torreyana,[13,18,28]
LignansLariciıesinol, taxiresinol, 3’-demethylisolariciresino1-9’-hydroxyisopropylethe, isolariciresinol, deoxypodophyllotoxin, (−)-secoisolariciresinol, 3, 3-demethylisolariciresinol, isotaxiresinol 2, α-conidendrin, (+)-pinoresinol, (−)-matairesinol, arctiin, dibenzylbutyrolactol, (−)-wikstromol, (−)-traxillagenin, (−)-arctigenin, traxillaside, 4′-deme-thyltraxillagenin, [(2R,3R)-2-(4′’-hydroxy-3′’-methoxybenzyl)-3-(4′-hydroxy-3′,5′dimethoxybenzyl)-butyrolactone]T. baccata, J. taxifolia, J. sabina, J. virginiana, J. virginiana, P. roxburghii, Cedrus deodara, T. nucifera[29,30,31,32,33,34,35]
Polyphenols: Flavonoids
FlavanonolsTaxifolin, cedeodarinC. deodara, L. simbraca, P. roxburghii, P. mariana, P. abies, A. pindrow, A. excelsa; P. pinea, P. halepensis, P. pinaster, P. gerardiana[33,36,37,38,39,40]
FlavonesPilosanol B, luteolin, apigenin, apigenin 6-C-b-glucopyranosideP. mariana, A. excelsa, P. abies, P. sylvestris, P. menziesii, P. menziesii, J. communis, A. angustifolia, L. deciduas[18,38,39,41,42,43]
BiflavonesBilobetin, cupressuflavone II-7-O-methyl-robustaflavoneT. wallichiana, C. macrocarpa, A. angustifolia[43,44,45,46]
FlavonolsQuercetin, dihydroquercetin, rutin, kaempferol, dihydrokaempferolJ. communis, J. oxycedrus, P. gerardiana, P. roxburghii, P. wallichiana, A. angustifolia, P. abies, L. deciduas, P. sylvestris, P. menziesii, M. glyptostroboides, J. excelsa, P. mariana, J. foetidissima[18,33,41,42,43,47,48,49,50]
Flavan-3-olsMonomers: (−)-epicatechin, (−)-epicatechin-3-gallate, (+)-catechin, sennidin A, (−)-epigallocatechin,P. pinaster, P. pinea, P. halepensis, P. roxburghii, P. wallichiana, P. gerardiana, J. foetidissima, A. angustifolia, P. abies, L. deciduas, P. sylvestris, J. communis, P. menziesii, J. oxycedrus, M. glyptostroboides, J. excelsa[18,33,39,40,41,43,47,48,49,50]
Polymers: Procyanidin B1, B2, procyanidin A2,P. halepensis, P. pinea, P. pinaster[40]
Phenolic acids
Benzoic acidsp-hydroxybenzoic acid, 2,5-dihydroxobenzoic acid, gallic acid, 4-hydroxybenzoic acid, protocatechuic acid, ellagic acidP. abies, L. deciduas, P. sylvestris, P. menziesii, P. kesiya, J. communis, A. excelsa, P. roxburghii, P. wallichiana, P. gerardiana, L. deciduas, J. communis[33,38,41]
Hydroxycinnamic acidCaffeic acid, t-cinnamic Acid, p-coumaric acid, vanillic acid, ferulic acid, salicylic acid, sinapic acid, syringic acid, chlorogenic acid, 5-caffeoylquinic acid, caffeic acid 4-O-glucosideP. abies, L. deciduas, P. sylvestris, T. baccata, P. mariana, P. pinaster, P. kesiya, L. deciduas, J. communis, P. menziesii, M. glyptostroboides[18,21,39,41,42,49]
Stilbenestrans-resveratrol, resveratrol, trans-pinosylvin, cis-stilbenes, pinosylvin, dihydro-monomethyl, trans-stilbenes, trans-piceatannol, trans-piceid, trans-isorhapontin, trans-isorhapontigenin, phenanthrenes, astringin, trans-astringinP. mariana, P. abies, J. communis, P. pinaster, P. sylvestris, P. strobes, P. roxburghii, P. wallichiana, P. gerardiana, P. merkusii[8,18,39,51,52,53,54,55,56,57]
It is also important to keep in mind the strong tendency towards adaptation, certainly not comparable with that of the subsequent Angiosperms, of which the dominance of the Araucaceae in the southern part of South America is a shining example [58]. Once again, it appears evident that the climatic situation constitutes the determining factor in the evolutionary path, as evidenced by the residual dominance of the conifers in the environments suited to them. There is therefore a lot to explore relating to conifers, and it is useful to develop studies entirely dedicated to individual genera [59].
From the chemotaxonomic point of view, it is necessary to highlight how difficult it is to study the chemistry of conifers due to the lack of easily usable markers [60]. In fact, resin and phenolic compounds, including tannins, have proved, due to their complicated composition and wide variability, difficult to study and not suitable for deducing clear considerations from them. First of all, we must not forget the unsuccessful attempts, the once well-developed branches that are now essentially exhausted, of which Ginkgo is a sensational example, to which we can add the genus Taxus [61]. It is no coincidence that these species are now a source of drugs of great therapeutic importance. It is therefore possible that there is still a lot to investigate and study on the chemistry of conifers. A starting point is represented by the collection of the current scientific knowledge recorded so far and the possible use of these data in the light of the most recent interpretations and possible therapeutically interesting utilizations. In this sense, the main focus of this review is to emphasize conifers’ phytochemical compounds with a broad range of applications and as a source of molecules for drug development.

2. Conifers Phytochemicals Components

2.1. Terpenes

Terpenes are isoprenoids not containing nitrogen and sulfur and seem to be the main and largest group of natural phytochemicals group in conifers [12]. The terpenoids can be classified as C5 (hemiterpenes), C15 (sesquiterpenes), C20 (diterpenes), C10 (monoterpenes), C25 (sesterpenes), C40 (tetraterpenes), C40 (polyterpenes), and C30 (triterpenes) on the basis of C5 units [62]. Table 1 represents the most common mono-, sesqui- and diterpenes present in conifers. In particular, monoterpenes have been extensively studied, especially for their antiviral properties. Further, Porres-Martínez et al. (2016) reported their biological activities, including the anti-inflammatory, anticancer, antioxidant, and neuroprotective effects [63]. However, taxol diterpene derived from Taxus spp. have potential against malaria and cancer [62]. Sesquiterpenes have antiseptic, antimicrobial and disinfectant properties [64]. Kopaczyk et al. (2020) showed that the antioxidant activity of terpenes can prevail over oxidative stress aggravated by internal and external stimuli [12].

2.2. Alkaloids

There are several classes of alkaloids which are classified on the basis of the heterocyclic ring system and biosynthetic precursor which are of great interest. The alkaloids comprise quinolizidines, indoles, tropanes, pyrrolidines, pyrrolizidines, imidazoles, piperidines and isoquinoline purines [65]. There are numerous studies on the biological activity and medicinal uses of alkaloids [66]. In addition, alkaloids have been shown to have antitumor, anti-hyperglycemic and antibacterial activities [13]. Virjamo et al. (2020) reported that among the piperidine compounds of P. abies, only 1,6-dehydropinidine exhibited antibacterial effects by using a larger number of strains, whereas cis-pinidine was revealed to be toxic for vertebrates, which may only act in defense against herbivores [13].

2.3. Polyphenols

Polyphenols are of major relevance and perform a range of functions from skeletal constituents in various tissues to pigmentation in many plant organs [67]. They act as natural antioxidants, being able to inhibit lipid peroxidation, carcinogenesis, antimicrobial activity, direct capillary constrictive action, phytohormones, and have also the ability to stabilize ascorbic acid [68]. Flavonoids (isoflavones, flavonols, flavanonols, flavones, tannins, flavanones, anthocyanidins), stilbenes (resveratrol), phenolic acids (hydroxybenzoic and hydroxycinnamic acids), lignans, can all be found in plants [69]. Polyphenols, especially flavonoids, such as rutin, quercetin, apigenin, and epicatechin, are widely found in conifers. The genera Araucaria, Pinus, Cedrus, etc. are reported for their antimicrobial, anticancer, antidiabetic, neuroprotective [43] and anti-inflammatory properties and can be used in the treatment of neurodegenerative diseases, as well as being helpful in reducing αβ toxicity and neuronal dysfunction [70].

2.3.1. Flavonoids

Flavonoids are the most abundant phenol group in nature, present in a wide range of conifers [71]. Flavonoids have a central three-ring structure, but the different subclasses vary due to the centrally located heterocyclic ring structure (C-ring), which connects the two benzene rings [72]. To date, more than 6000 flavonoids have been recorded in several studies from plants. Flavonoids are aglycones in their basic structure, but most of them are glycosides in plants [73]. The subclasses of flavonoids found in the leaves, barks and seeds of conifers are represented in Table 1.

2.3.2. Lignans

Lignans are phenylpropanoids dimers made up of two coniferyl or sinapyl alcohol units bound together at the tails [74]. Isolariciresinol, taxiresinol, lariciresinol, pinoresinol, and their glycosides are examples of such compounds. There is a growing interest in lignans, especially because of their chemotherapeutic ability [75]. The most commonly present lignin compounds in conifer spp. are shown in Table 1.

2.3.3. Stilbenes

Stilbenes are produced by a number of conifer species, including Pinus sylvestris and Picea abies. Briefly, stilbenes are phenolic compounds with a heterologous bridge connecting two aromatic rings [76]. Many other compounds, such as trans-pinosylvin, cis-stilbene, resveratrol and piceatannol, have been isolated from the barks of conifer species (Table 1). For stilbenes, excellent antimicrobial effects have been reported [71].

2.3.4. Tannins

Tannins are polyphenolic compounds that can be in a wide range of plants. Tannins are colored pigments, astringent and are characterized by a bitter taste [77]. Tannin-rich conifer bark extracts have antimicrobial properties and high potential in preventing lipids from oxidation in the liposome model [78]. As a result, the tannins can be divided into four main classes based on their structural characteristics: gallotannins, complex tannins, ellagitannins and condensed tannins [79]. Condensed tannins (CTs), also well-known as proanthocyanidins, are prevalent in P. abies and P. sylvestris tree bark [77]. Condensed tannins are considered as polymers or oligomers of flavan3-ol units connected by C-C bonds that are hydrolysis resistant [80]. Procyanidins (PCs) and prodelphinidins (PDs) are the most popular PAs. Catechin and other epicatechin units make up PCs. Epigallocatechin units make up PDs [81].
Tannins exhibit antioxidant activity through various pathways, including free radical scavenging, transition metal chelation, and inhibition of pro-oxidative enzymes [82], besides having the capability to bind and form complexes with proteins and other compounds, and being responsible for their biological activity [83]. Tannins also act as antimicrobial agents, inhibiting extracellular microbial enzymes, depriving microbial growth substrates, and exerting a direct action on microbial metabolism, such as the denaturation of cell membrane proteins [84]. In the food industry, they could be used as functional coatings, adhesives, preservatives and as flavor compounds [71]. In a study, pine and spruce bark-derived PA-rich extracts revealed good potential for use in the food industry to develop preservative agents and to prevent lipid peroxidation in food items containing fatty-acids [78].

3. Traditional Medicinal Uses

Since prehistoric times, coniferous plants have been used as a medicinal source. Plant-based research has received more attention in recent years, and the literature supports the possible use of medicinal plants in conventional processes [85]. T. orientalis leaves and stems are utilized in traditional medicine to cure nervous system disorders, insomnia, heart palpitations, hemorrhage and fever. Fresh cedar leaves steeped for seven days in a 60% alcohol solution are often used by traditional Chinese physicians to encourage hair growth [86]. Cupressus spp. leaves, cones, stem bark have also been revealed to be useful in the treatment of hemorrhoids, bleeding varicose veins, asthma cough, spasms, diarrhea, rheumatism, common colds, piles, urinary tract ailments and vaginal discharge [7]. Different parts of the Pinus spp. bark, leaf, cone, and resin are also prescribed to treat cold-influenza, cough, tuberculosis, and bronchitis as a diaphoretic, rubefacient, antiseptic, diuretic, stimulant and febrifuge, while resin is also used in wound healing and injury [87]. The extract from Juniperus spp. leaves, berries and bark has also been used for the treatment of chronic eczema, hyperglycemia, obesity, tuberculosis, bronchitis, and pneumonia. The female cones, wood and leaves of J. foetidissima, J. communis and J. excelsa are used as a tonic for gout and rheumatism, a carminative, a diuretic, a treatment for urinary tract infection and stomach ache, an expectorant, a stimulant, an emmenagogue, and a treatment for the common cold [7].
Different parts of Taxus spp. have precise ethnomedicinal uses; for example, the leaves’ juice is used to cure cancer and bronchitis; bark juice and other parts, such as the leaf, are used for asthma and bronchitis, while trunk oil and cones are used to treat sheep diseases, bad breath, halitosis, inflammatory diseases of the lower urinary tract, renal stones, urinary infection, rheumatism dyspeptic complaints, hemorrhoids and cancer [7,88], and powdered dried leaves are considered to be effective in epilepsy, asthma, headache, diarrhea, bronchitis and hiccoughs [89]. A decoction developed from the bark is used to relieve pain from the muscles, knees, and rheumatoid arthritis, whereas a decoction made from the leaves is used to treat liver issues [90].

4. Conifers Extracts Rich in Phytochemical with Putative Health Effects

4.1. Oxidative Stress

The role of oxidative stress in the progression of degenerative ageing is well understood. Diabetes mellitus, coronary heart disease, cancer, inflammation, stroke, neurological conditions (e.g., AD), and ageing have all been linked to reactive oxygen species (ROS) generation [49]. Both enzymatic and non-enzymatic reactions are involved in the synthesis of ROS. ROS are known to be generated by enzymatic reactions present in many cell processes, including the respiratory chain system, prostaglandin synthesis and phagocytosis [91]. All ROS are produced through enzymatic action, including NADPH oxidase, xanthine oxidase and peroxidase in many cell processes, in whom the superoxide radical (O2●−) is generated [92]. Different ROS, formed during enzymatic reactions and with the action of enzymes (amino acid oxidase and xanthine oxidase), include hypochlorous acid (HOCl), hydrogen peroxide (H2O2), peroxynitrite (ONOO-), and hydroxyl radicals (OH) [93]. The “Fenton reaction” between O2− and H2O2 takes place in the presence of Fe2+ or Cu+, which work as catalysts, producing OH, the most reactive free radical species [94]. The production of ROS has been related to non-enzymatic interactions between oxygen and organic compounds, as well as when cells are in contact with ionizing radiation during mitochondrial respiration [94,95]. Extensive research is currently needed to discover phytochemical compounds with the ability to boost the immune system and reduce oxidative stress [96]. The quest for new antioxidant molecules is a crucial part of promoting healthy ageing and combating oxidative stress [93]. Flavonoids, phenolic acids, vitamins and carotenoids are examples of natural compounds with antioxidant potential that have antagonistic effects on degenerative and inflammatory processes throughout the body, have beneficial effects on the immune and digestive systems, prevent ROS-related chronic problems and improve the overall quality of life, as shown in Figure 3 [88].

4.2. Synergism between ROS and other Diseases

The overproduction of ROS has been linked to a variety of chronic diseases, including cardiovascular, inflammatory and neurodegenerative diseases, and even cancer. The following sections explain on the relationship between ROS and chronic diseases.

4.2.1. Antioxidant Activity

In chronic obstructive pulmonary diseases (COPD), ROS play an important role [97]. The bark, wood, needle, and cone extracts of the Pinaceae family are high in polyphenolic compounds (Pycnogenol), primarily procyanidins, stilbenes, tannins and phenolic acids, and have significant antioxidant activity against ROS [98]. The antioxidant activity of conifer extracts has been confirmed by DPPH, FRAP and reducing power assays [51].
Flavonoids’ ability to scavenge free radicals can protect the human body from oxidative damage, which accelerates the ageing process [99]. Pycnogenol®, a polyphenol-rich compound extracted from the bark of P. pinaster, P. glauca, and P. mariana, has shown the ability to boost plasma antioxidant capacity and ameliorate pulmonary function and asthma traits [51,100]. In a study by Senthilmohan et al. (2003), 6–12 weeks of supplementation of Enzogenol®, and proanthocyanidin-rich flavonoid extracted from Pinus radiata bark in combination with vitamin C reduced DNA and protein oxidative damage in 55–75-year-old people [101]. In vivo studies have reported that the intake of quercetin alone did not protect DNA, but the combination of flavonoids (quercetin and myricetin) and isoflavonoids provides protection against DNA damage [102]. It has been found that the stilbenoid component resveratrol and piceatannol obtained from conifer spp. have more potent biological activities, namely as antioxidants [103]. Terpenoids and phenolic compounds, such as pinene, lycopene, camphene, gallocatechin, lutein, limonene and catechin found in the extract of conifer bark and needles have also been reported for their antioxidant potential by DPPH, FRAP, H2O2, ABTS assays, as shown in Table 2 [104].

4.2.2. Anti-Inflammatory Activity

When contagious microorganisms such as fungi, bacteria and viruses come into contact with the body, they remain in specific tissues and flow into the bloodstream, causing inflammation [105]. This also occurs as an end result of tissue damage, cancer, cell death, degeneration and ischemia [106,107,108]. In most cases, both the innate and adaptive immune responses are responsible for inflammation development [109]. The primary protection against invading foreign microbodies and cancer cells is the innate immune system, which involves macrophages, dendritic cells, and mast cells [105]. In the adaptive immune system, specialized cells (B and T cells) remove foreign pathogens and cancer cells by generating specific receptors and antibodies [110]. Cytokines such as interleukins, interferons, tumor necrosis factor, eicosanoids (leukotrienes and prostaglandins), modulatory inflammation-transcription nuclear factor (NF-ĸB) and chemokines (monocyte chemoattractant protein 1), are the inflammatory mediators and cellular pathways that have been extensively studied in relation to human pathological conditions [111]. Tumor necrosis factor-α (TNF) is a pro-inflammatory cytokine that is secreted by a variety of cells and has a variety of cellular effects [112]. It has also been linked to a variety of human illnesses, including cancer, mental and skin disorders, immune and inflammatory diseases. IL-1 is another cytokine that primarily has a pro-inflammatory effect [113]. It raises the levels of pro-inflammatory cytokines, including IL-1, TNF and IL-6 [114]. On the other hand, IL-1 has been linked to anti-inflammatory properties. Likewise, IL-1α and IL-6 originating from activated mast cells in the innate immune response also boost acute phase protein synthesis and thus show some anti-inflammatory effects [115]. The cytokine family members, including IL-12, IL-27, IL-23 and IL-35, function as a pro- and anti-inflammatory response [111,116,117]. On the other hand, IL-10 has been recognized as an effective anti-inflammatory cytokine, and helps in preventing several pro-inflammatory mediators from further action [118]. It protects tissue from homeostasis, defends against injury and damage caused by an overactive inflammatory response [118,119,120]. TNF-α accelerates PGE2 synthesis changes caused by edema and the flow of blood [46]. The extraction of plant materials is the first step in deciding the plant biological activities. The is a high probability of synergism between bioactive components when a whole extract is used, which could be lost if each and every component is isolated [121]. This form of synergism has been documented in numerous medical studies, generally for anti-inflammatory function [105]. There are different types of extraction and separation processes, such as:
1. Soxhlet extraction: The Soxhlet extraction method is a more efficient extraction method with high extraction yield and requires less solvent and time. This method requires electricity and solvents such as methanol, petroleum ether, and acetonitrile for the extraction process. However, sometimes high temperature and long extraction time enhance the possibility of thermal degradation and the loss of bioactive compound fraction activity [122].
2. Percolation: Extraction yield is better in percolation than maceration; in this process, pre-soaked plant material is added to a container, which allows the constantly controlled removal of the extract via a valve at the bottom and adding fresh solvent from the top.
3. Maceration: Maceration is carried out at room temperature by soaking the material with the solvent with eventual stirring. It has the advantage of moderate extraction conditions but suffers from high solvent consumption, long extraction times and low extraction yields. It could be used for the extraction of thermo labile components.
4. Ultrasound-assisted extraction: In UAE, the plant material, usually in a glass container, is covered by the extraction solvent and put into an ultrasonic bath. It decreases extraction time and improves extraction yields due to mechanical stress, which induces cavitation and cellular breakdown, and has gained increasing popularity [123]. For the isolation of extract from the solvent, the distillation process and many evaporators are used. After isolation to concentrate the extract, many researchers used a rotary evaporator, a normal air-drying process and distillation methods. Generally, to separate different solvent extracts, a separatory funnel is required [124].
Anti-inflammation is one of the main recorded effects of conifer phytochemicals among the numerous biological activities that have been studied so far. Table 3 reported the anti-inflammatory effect of conifer phytochemicals in in vivo and in vitro models.
Cupressuflavone (CUF) isolated from C. macrocarpa has the ability to reduce the levels of several cytokines, including IL-1b, IL-6, TNF-α and PGE2, in plasma dose-dependently, and thus acts as an anti-inflammatory agent [46]. Triterpenoids and abietane type’s compounds extracted from Abies chensiensis show anti-inflammatory effects against NO production in RAW 264.7 macrophage cells [125]. It has been found that tasumatrol, deacetylbaccatin, paclitaxel and many other terpenoids extracted from Taxus spp. are effective in the anti-inflammatory process initiated through the carrageenan and cotton pellets induced edema model [21,22]. Kyung-Jae Cha. (2016) reported that in atopic dermatitis, the Picea wilsonii mast extract is useful and potent only in the inhibition of the production of the inflammatory cytokines IL-6, MCP-1 and IL-13, without significant change in IL-8 production induced in human adult low-calcium high-temperature (HaCaT) cell lines [115]. T. occidentalis mother tincture-containing terpenoids (thujone), polyphenols and flavanoids have potential in reducing ulcerative colitis inflammation in the mouse intestine and rectum by decreasing the stimulation of the pro-inflammatory cytokines IL6 and TNF-α induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) [126]. THP-1 cell adhesion to TNF was suppressed by enzogenol at a concentration of 5–25 g/mL onto TNF-α-activated human umbilical vein endothelial cells (HUVEC) by reducing integrin β2 induction and inhibiting monocyte trans-endothelial migration [127]. The anti-inflammatory and platelet-inhibitory effects of pycnozenol, extracted from Pinus maritime bark extract, inhibited the activity of cyclooxygenase (COX)-1 and COX-2 present in human plasma [128]. Inflammation has been attributed to cancer and neurodegenerative diseases [46].

4.2.3. Anticancer Activity

According to the report by the World Health Organization, cancer was a major cause of death in 2018, with a death rate of 9.6 million people [129]. Hippocrates, before 370 B.C., coined the word “cancer” to describe carcinoma tumors [130]. On the basis of evidence, bone cancer was identified in Ancient Egyptian mummies in around 1600 B.C., and cancer of the breast was identified in 1500 B.C., although there is no record of a cure for cancer [131]. Giovanni’s research laid the foundation for scientific cancer techniques in 1761, when he performed the first autopsies on dead human bodies to determine the connection between a patient’s disease and their death, as well as pathologic studies [132]. Cancer has been identified as the chief matter of public health concern around the world [133]. Surgery, radiotherapy, and chemotherapy are some of the conventional cancer treatments [134,135]. On the other hand, despite the use of a variety of synthetic drugs for cancer treatment and the successful completion of different management schedules, current therapies are not able to achieve the desired results, as tumor relapse and metastasis are common [136]. Nature contains various chemicals and pharmacologically active substances which act as anticancer drugs [137]. Recently, many of the phytochemicals and synthetic analogs, such as HS-1793 (resveratrol), have been identified as inhibiting the growth of cells and inducing apoptotic cell death, helping to cure cancer [138]. While only a few phytochemical compounds obtained from natural products have been developed into clinically active drugs, their bioactive components may be used as a basis for the development of more successful analogues and prodrugs using chemical techniques such as metabolomics, complete or combinatorial fabrication, and biosynthetic pathway modification [139]. Many phytochemical compounds are highly efficient in inducing apoptosis and cytotoxicity by modulating different MAPK andAKT/PI3K pathways, and suppress cancer cells line invasion and migration potential along with the stimulation of senescence phenotype, regulation of Bax or p53 genes, cell cycle arrest and modulation of IL-8, IFN-γ, TNF, IL-6 [140]. Many of the compounds derived from conifers’ bark and leaves act as antitumor drugs, such as paclitaxel (PTX) (trade name Pycnogenol® and Taxol®), a diterpene found in the crude extract of P. pinaster and Taxus brevifolia bark [141]. Paclitaxel, as well as its analogues docetaxel (taxoteres) and jevtanas (cabazitaxel), are examples of chemotherapeutic synthetic analogues derivative from plants that have been formulated and validated clinically [139]. By binding microtubules, PTX and other microtubule-targeting agents (MTAs) induce cellular death [142]. Microtubules are tubulin heterodimers that play a role in disease and perform numerous cellular functions including transport, force production in cell division, and structural support [143]. During the G2 phase of the cell cycle, tubulin is produced, and microtubules are assembled. Microtubule stabilizing agents, such as PTX, bind to α/β tubulin in order to disassemble microtubules. As a result, they cause cell death and are used as an anti-cancer agent [144]. In general, cells exposed to PTX are stuck in the G2/M phase, resulting in death due to failure to move through the cell cycle [145,146]. Recently, a study published in 2017 found that pycnogenol and PTX at doses of 20 g/mL and 0.5 μM cause DNA and mitochondrial damage in cancer breast cell line (MDA-MB) in 24 h, and concluded that it is possibly a target drug for cancer treatment through DNA and mitochondrial damage mechanisms [141]. From different conifer species crude extracts, the anticancer activities on different cancer cell lines are summarized in Table 4.
Table 2. Antioxidant capacity of extracts obtained from different conifer spp.
Table 2. Antioxidant capacity of extracts obtained from different conifer spp.
Conifer spp.Part UsedCompoundsNature of ExtractRadical Scavenging AssayDose/ConcentrationMain EffectsReferences
Aurocaria cookiiLeavesPhenolic compoundsMethanol, chloroform, petroleum etherDPPH1000 μg/mLMethanol extract shows the best antioxidant activity with 63% inhibition, higher than the other two compounds[147]
A. excelsaNeedleFlavanoidsMethanolDPPH50–72.5 μg/mLMethanol/water extract shows antioxidant activity[38]
C. deodaraHeart woodTannins, flavonoids, and phenolic compoundsWater/alcoholDPPH, superoxide radical-scavenging activity, ABTSDPPH-IC50 (μg/mL): 61.89 (water extract),
75.79 (alcohol extract)
superoxide radical-scavenging activity—
IC50 (μg/mL): 87.76 (water extract), 121.55 (alcohol extract).
ABTS-IC50 (μg/mL): 115.29 (water extract), 122.42 (alcohol extract).
DPPH radical-scavenging activity and the reducing power of C. deodara were potent in water and alcohol extract[148]
C. japonicaAll partsPhenolic compoundsMethanolORAC,
4.09–7.64 TE/mg
The methanol extracts from each part of C. japonica except for pollen showed strong activities in the bioactivity assays.[149]
J. communisBerryFlavanoids (quercetin rutin,
apigenin) chlorogenic acid
Alcohol/WaterDPPHEC50 1.42 mg/mL against standard Ascorbic acidEC50 value of 0.365 mg/mLThe antioxidant activity was confirmed as 81.63 ± 0.38% by the DPPH assay.[42]
L. laricinaBarkPhenolic compoundsEthanol/WaterORACIC50 0.878 μg/mL.Bark extract of LL shows significant antioxidant activity[51]
Metasequoia glyptostroboidesConeTerpenoidEthyl acetateDPPH, NO, superoxide, and H2O25–250 μg /mLSugiol derived from cone extract show good antioxidant activity—78.38, 72.42, 74.45 and 85.04%, respectively.[26]
Picea abiesBarkAtilbenoidsEthanol/WaterDPPH49.74 μg/mLUVA-induced modification of the stilbene-rich inner bark extracts increased the antioxidant activity as UVA irradiation decreased the capacity of the extracts to prevent lipid oxidation in the liposome system method[53]
P. smithianaLeavesPhenolic compoundsMethanolDPPHIC50 (μg/mL)-Results of the DPPH radical scavenging activity and FRAP study determine that methanol extracts of leaf displayed the highest antiradical efficiency[150]
Reducing Power assay978
Pinus gerardianaBarkPhenolic compoundsEthanolDPPHIC50 value μg/mLP. gerardiana shows promising H2O2 radical scavenging activity[104]
P. halepensisBarkPhenolic compoundsEthanol/Water IC50 (μg/mL). Ethanol and the waterEthanol and water extract of bark exhibited significant free radical neutralization capacities, at conc. 0.5–8 μg/mL[151]
DPPH3.28, 3.26
ABTS3.1, 3.59
P. pinasterBarkPhenolic compoundsEthanol/Water PB (50%) and (90%) IC50 value μg/mLPP bark extracts formed from PB 50% (50% ethanol) have maximum (DPPH, ABTS) radical scavenging activity while FRAP shows activity with (PB 90%)[39]
P. roxburghiiBarkPhenolic compoundsEthanol IC50 value μg/mLPine extract shows significant antioxidant activity[104]
P. wallichianaBarkPhenolic compoundsEthanol IC50 (μg/mL)Pine extract shows significant radical scavenging activity[104]
Thuja occidentalisLeavesFlavonoids, phenolsMethanol DPPH, FRAP20–100 μg/mLCrude extract shows significant antioxidant activity[152]
T. occidentalisNon-woody
branches with leaves
Polyphenol, flavonoidsMother tincture (MT)DPPH, ORAC, NO25 or 50 mg/kg T. occidentalis mother tincture displayed 88.3% antioxidant activity by DPPH and about 78% by NO assay[126]
Taxus baccataLeaves and
Flavonoids, phenolsMethanolDPPHIC50 (μg/mL) 105.41, 518.51 leaves and cones resp.Acetone and ethyl acetate extract of leaves show good scavenging activity[153]
WaterDPPH533.66, >1000 leaves and cones resp.
AcetoneDPPH25.24, 81.43 leaves and cones resp.
Ethyl acetateDPPH29.84, 180.26 leaves and cones resp.
Petroleum etherDPPH438.92, > 1000 leaves and cones resp.
T. wallichianaLeavesTerpenoids, flavonoids IC50 values (μg/mL)The maximum DPPH activity was observed in methanol extract (91.25%), followed by water (87.64%), ethanol (85.23%), and ethyl acetate (83.27%) at the highest concentration (700μg/ml)[154]
MethanolSuperoxide radical170.30
Hydroxyl radical82.34
Ethyl acetateSuperoxide radical297.55
Hydroxyl radical199.05
WaterSuperoxide radical257.00
Hydroxyl radical175.33
T. wallichianaLeaf, stemPolyphenols, flavanoids, terpenoidsMethanolDPPH
IC50 value (μg/mL.)
Leaves (23.18)
Stem (56.75)
DPPH and FRAP activity of TW leaves and stem extract have high antioxidant activities.[155]
PB-Pine bark; TW-Taxus wallichiana.
Table 3. Anti-inflammatory capacity of different conifers spp.
Table 3. Anti-inflammatory capacity of different conifers spp.
Conifer spp.Part UsedNature of ExtractCompoundsMajor Method(s) of TestingDose. ConcMain EffectReferences
Abies chensiensisTwigs and leavesEthanolTerpenoidsInduce lipopolysaccharide to produce inflammation in RAW 264.7 macrophage cells0.2–50.0 μM4 compounds—3α-hydroxyl-8,14,22Z,24-tetraenlanosta-26,23-olide; (5R,20R)-8(14→13R)-abeo-17,13-friedo-3-oxolanosta-8,14(30),22Z,24-tetraen-26,23-olide;
and (23R, 25R)-3,4-seco-9β H-lanosta-4 (28),7-dien-16α-hydroxyl-26,23-olid-3-oate—extracted from extracts showed significant anti-inflammatory activities of inhibition against NO formation with IC50 value of 15.9, 18.7, 20.18, and 10.9 μM
A. georgeiAerial partsChloroform, ethyl acetate, n-butanolFlavanoidsdimethylbenzene-induced ear oedema in mice200 mg/kgAG ethyl acetate extract shows 18% inhibition against dimethylbenzene-induced ear edema in mice while carrageenin-induced paw edema in rats shows inhibition ratios 28.2% and 35.6%, after 2 and 6h, respectively.[156]
Carrageenin-induced paw oedema rat140 mg/kg
A. webbianaLeavesMethanol/Petroleum ether extractFlavanoidsCarrageenan-induced rat hind paw edema model in Albino mice400 mg/kgPlant leaves extract possesses significant anti-inflammatory properties[157]
Agathis robustaLeavesMethanolFlavanoids, tannins and saponinsHeat induced hemolytic method in human red blood cell (HRBC) membrane400 μg/kgLeaves extract shows good antiinflammatory activity[158]
Cedrus deodaraStem barkMethanolDeodarin, quercetin, taxifolinCarrageenin-induced paw edema in Albino rat100 mg/kgAnti-inflammatory activity with 43.47% inhibition[159]
Cupressus macrocarpaLeavesMethanolCupressuflavone (CUF)Carrageenan-induced paw edema model in Mice40, 80, and
160 mL/kg
CUF demonstrated antiinflammatory
activity by inhibiting paw edema with 55, 60, and 64%, by decreasing the plasma pro-inflammatory mediators PGE2, IL-6, TNF-a and IL-1b
Juniperus communisBerryAlcohol/WaterFlavanoids (quercetin rutin, apigenin) chlorogenic acidAcute-dextran and kaolin subacute inflammation induced in Wistar Rat10 mL/kgThe antiinflammatory action of the juniper extract, administered as a microemulsion in acute-dextran model was increased when compared to kaolin subacute inflammation induced model.[42]
J. oxycedrusBerryEthanol, n-butanolFlavonoids (amentoflavone, cupressuflavone, hinokiflavone, and rutin)Carrageenan-induced hind paw edema model in mice100 mg/kgEthanol extract of Joso berries displayed remarkable inflammatory inhibition ranging between 24.5% and 23.7% at 100 mg/kg in carrageenan-induced edema model[160]
J. foetidissimaBerryEthanolFlavonoids (amentoflavone, cupressuflavone, hinokiflavone, and rutin)carrageenan-induced hind paw edema model in mice100 mg/kgJFB extract at a dose of 100 mg/kg. shows high antiinflammatory effect 26.9%[160]
Pinus gerardiana, P. roxburghii, P. wallichianaBarkEthanolFlavanoid, tanninagainst albumin denaturation, HRBC membrane stabilization assay2500 μg/mLP. roxburghii extract showed highest (%) of inhibition and protection i.e 86.54 and 89.92 against albumin denaturation and HRBC membrane stabilization. However, P. wallichiana have least inhibition and protection percentage, i.e., 76.54 and 81.2%[104]
Taxus baccataAerial partsMethanolTerpenoidsear edema induced in mice3.2 mg/earT. baccata extract displayed best activity[21]
T. baccataBarkEthanolAlkaloids, terpenoids, flavonoidscarrageenan-induced paw edema in Wistar Albino rat200 mg/kgPercentage of inhibition is 44% at a dose of 200 mg/kg[161]
T. baccataHeart woodEthanolTaxoids, lignanscarrageenan-induced hind paw edema model inS wiss albino mice30–100 mg/kgTBW shows significant antinociceptive and anti-inflammatory activities[29]
T. wallichianaBarkMethanolTasumatrol B, 1,13-diacetyl-10-deacetylbaccatin III (10-DAD) and 4-deacetylbaccatin III (4-DAB)carrageenan-induced paw edema and Cotton-pellet oedema model in Wistar rats and Swiss albino mice20 and 40 mg/kg; 40 mg/kgIn a carrageenan-induced inflammation model, tasumatrol B at a dose of 20 mg/kg showed significant activity, while in a cotton-pellet edema model tasumatrol B was found to be highly significant at the dose of 40 mg/kg.[22]
Thuja occidentalisNon-woody branches with leavesMother tincture (MT)Polyphenols, flavonoidsAdministered 2,4,6-trinitrobenzenesulfonic acid to induce intrarectal colitis in mice25 or 50 mg/kgMT manage to relieve intestinal inflammation experimentally induce by TNBS in 7 days.[126]
JFB—Juniper foetidissima berry; AG—Abies georgei; TBW—Taxus baccata heart wood.
Table 4. In vivo and in vitro anticancer and cytotoxic studies of conifer extracts.
Table 4. In vivo and in vitro anticancer and cytotoxic studies of conifer extracts.
Conifer spp.Part UsedNature of ExtractCompoundsIn Vitro and in Vivo ModelDose. ConcMain EffectsReferences
Abies georgeiAerial partsChloroform, ethyl acetate, n-butanolFlavanoidsHuman tumor cell lines-A549, QGY-7703, LOVO, 6T-CEM77.5, 11.1, 7.8, 32.8 μg/mLAGC extract has potent tumour and antiproliferative effects in humor tumor cell lines[156]
(Mice) S180 tumours cell lines100, 200 and 400 mg/kgAGC also exhibited activity in tumour growth inhibition in a dose-dependent manner, with ratios of 46.7, 53.1 and 31.0% at doses of 100, 200 and 400 mg/kg, respectively
Araucaria angustifoliaFemale strobiliWaterFatty acids and polyphenolsLaryngeal carcinoma HEp-2 cells100–500 μg/mLAAE inhibit the activity of mitochondria complex I and induce redox stress and cytochrome c, which leads cleavage of nuclear proteins of larynx HEp-2 cancer cells[162]
Cedrus deodaraStem woodChloroformLignans (Matairesinol, dibenzylbutyrolactol, (−)-Wikstromol)In vitro human cell lines (cervix, breast, colon, liver, CNS, prostrate)In vitro cytotoxicity IC 50 value-Wikstromol (71.31–93.63) and Matairesinol (50.84–95.36) μg/mLCD lignin mixture have potent to show a cytotoxic effect at the maximum in CNS and at the minimum in liver against cancer cell lines in a dose-dependent manner at 100 μg/mL from 49 to 95%.[34]
Human T lymphoblast, acute lymphoblastic leukemia cell line, Molt-4 and human promyelocytic leukemia cell line (HL-60)IC50 (μg/mL)
AP9-cd-induced endogenous NO production leads to the generation of peroxide and disruption of mitochondrial membrane potential, leading to apoptotic pathway activation
Increase in sub-G0 fraction from 35 to 60% in 24 to 48h
In vivo swiss albino mice (K562 cells) The lignin mixture displays anti-cancer effects by regulating annexin V binding, intracellular caspase activities and DNA fragmentation
C. deodaraNeedleEthanolKaempferol, myricetin, isorhamnetin and quercetinHepG2 cellsIC50 114.12 μg/mLTFPNCD shows potent cytotoxicity by inhibiting the growth of HepG2 cells in a dose-dependent manner
Regulates cell cycle and apoptosis
Cryptomeria japonicaLeavesMethanolFlavonoidsAlbino mice of Ehrlich Ascites Carcinoma (EAC).100–400 μg/gmTumor cell count as well as the amounts of ascetic tumour cells in packed cells were significantly reduced in infected mice treated with MC[165]
Juniper communisBerryMethanol and water Phenolic compoundsCaCo2 and HeLa carcinoma cell linesIC50 1300–2500 μg/mLMethanol and water extracts of JCB show potent antiproliferative activity against cancer cell lines[166]
J. taxifoliaLeavesChloroformPolyphenols and lignanhuman leukemia (HL-60) cells2.5 μg/mL7α-hydroxysandaracopimaric acid, a diterpenoid compound obtained from J. taxifolia leaves, shows antitumor effects on HL-60 cells[24]
J. phoeniceaAerial partsChloroformPolyphenols IC50 values (μg/mL)It is found that JPCF disrupts cell cycle progression in the G0/G1phase and shows apoptotic, antiproliferative and necrotic effects on cancer cells lines[20]
Human lung (A549)34.2
Breast (MCF-7)24.5
Liver (HepG2) cancer cells57.6
J. foetidissimaNeedleMethanolQuercetin, rutinRat brain tumor (C6) cell linesIC50 values (μg/mL)
J. foetidissima needle extract showed significant antiproliferative activity[50]
M. glyptostroboidesLeafWaterPolyphenolsPC12 cells25 μg/mLM. glyptostroboides leaf extract shows a cytotoxic effect and prevents oxidative damage of neuronal PC12 cells, protecting them from apoptosis; it was also found to significantly inhibit the release of LDH, which may result from apoptosis or necrosis[49]
Picea wilsoniiWhole plantDMSONDHuman keratinocyte HaCaT cell lines1–3 g/mLPwM extracts inhibit the production of MCP-1 IL-6, IL-13 and but do not inhibit IL-8 production[115]
Pinus kesiyaWoody twigEthanolPhenolic compounds and flavonoidsHuman hepatocarcinoma (HepG2) cell linesIC50 (μg/mL) 52.0PK Extract exhibited a potent cytotoxic effect in the HepG2 cell line[167]
P. kesiyaBranchEthanolPhenolic compounds and flavonoidsHuman leukemic U937
cancer cells
IC50: 299 μg/mLPK ethanol extract possesses anticancer activity against U937 human leukemic cells via apoptosis[168]
P. merkusiiLeavesMethanolPhenolic compoundsMCF-7, A549, HT 1080 and HepG2 Huh-7 cancer cell linesIC50 (μg/mL)
4.5, 16, 4.1,
5.6, 9.5
PM methanol extract possesses anticancer activity against human cancer cell lines[169]
T. baccataLeaves, conesMethanolPhenolic compoundsHCT-116 human colon cancer and MDA-MB-231 human breast cancer cell linesIC50 μg/mL
Leaves: 14.43 and 4.59 cones: 49.69 and 133.53
Methanol extracts of leaves had better activity on HCT-116 cells than seed cone extract, with IC50 values of 14.3 for 24 h and 4.59 for 72 h. Meanwhile, extracts did not show any significant cytotoxic effects on the cancer cell lines[153]
T. wallichianaHeartwoodMethanolLignans 1 (taxiresinol 1) 2, 3colon, ovarian liver, and breast cancer cell linesIC90 lignan 2 and 3 μg/mL
Caco 2:0.08 and 0.056 and 0.251
Taxiresinol 1 shows anticancer activity against ovary, colon, liver and breast cancer cell lines, while lignans 2 and 3 were found to be most active against Caco-2 cell lines[170]
T. yunnanensisAll partsNDα-ConidendrinMCF-7 andMDA-MB-231 cancer cell lines40 μMα-conidendrin have the potential to inhibit human breast cancer cell lines MDA-MB-231 and MCF-7, showing viability of 73 and 82%, respectively[31]
P. roxburghiiLeavesWater and ethanolPhenolic compoundsA549 human lung cancer cell line111.2 and 112.7 μg/mLPRL extract shows potent anticancer activity against cancer cell lines.[171]
Taxus cuspidataBranches and leavesWaterPolysaccharidesMCF7IC50 μg/mLPurified polysaccharides (Pe4) on HeLa cells had the highest inhibitory effect, and its IC50 value is 89.9, while (Pe1) shows the best cytotoxic capacity against cancer lines HepG2 and MCF7, with IC50 conc. 132.0 and 169.0 μg/mL, respectively[172]
Thuja occidentalisLeaves and non-woody branchesMother tincture (MT)Polyphenols including flavonoidsCaco-2 cells25 or 50 mg/kgCaco-2 cells exposed to H2O2 and T. occidentalis MT proves its radical scavenging activity by reducing GSH level by 103% and 98% as compared to TNBS group; MT also managed to reduce the lipid peroxidation[126]
T. occidentalisLeavesEthanolNDHuman NSCLC (A549) cell linesIC50 μg/mLExtract of TO shows both anticancer and antiproliferative activities against NSCLC (A549) cell lines in a dose-dependent manner.[173]
Human normal embryonic cell lines (L-132)376
T. occidentalisNDMother tincture (MT)
Thujone-rich fraction (TRF)
ThujoneA375 human malignant melanoma cell line200 μg/mLTRF as compared with TO MT on exposure to A375 cells exhibited highly cytotoxic, apoptotic and antiproliferative effects, but TRF shows a lower growth inhibitory response towards peripheral blood mononuclear cell (normal cells)[174]
ND—Not determined; AGC—Abies georgei chloroform extract; AAE—Araucaria angustifolia water extract; TFPNCD—total flavonoids from the pine needles of Cedrus deodara; PRL—P. roxburghii leaves.

4.2.4. Neurodegenerative Diseases

Neurodegenerative diseases (NDs) are more common among the elderly and may even lead to death, and so are a major threat in the 21st century [175]. AD, Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and the spinocerebellar ataxias are examples of ND [176], whose main features include nitrosative/oxidative stress, mitochondrial dysfunction, aggregated proteins accumulation, synapse loss, neuro-inflammation and decreased neuronal survival [177]. The progression of ND is also affected by genetic and surrounding ecological factors [175]. Indeed, it has been stated that the appropriate mechanism behind the cause of ND is mitochondrial dynamics variation, which elevates the oxidative damage, altering the biological activity of respiratory complexes, which results in brain energy dysfunction [178]. These stimuli trigger cellular stress, which leads to the synthesis and release of brain-derived neurotrophic factor (BDNF), as well as the activation of transcription factor CREB (cAMP response element-binding protein), with consequent expression of Arc (synaptic plasticity), PGC-1 (cellular energy metabolism), and APE1 (DNA repair enzyme), as well as the activation of the tropomyosin-related kinase (Trk B) receptor family and other downstream protein kinases [179].
Neurotrophins avoid neuron degeneration by binding to and activating the Trk receptor family, which is located in the plasma membrane [177]. Neurotrophins work by binding to and activating the Trk receptor family, which is found in the plasma membrane, to prevent neuron degeneration. Since neurotrosphins bind to Trk receptors, they create a microenvironment that promotes neuron development [180]. Various intracellular signaling pathways, such as ERK and PI3k/AKT, are regulated as a result of this binding, allowing cells to survive and aiding in the recovery of neurons from neurodegeneration. Additionally to signaling pathway activation, neurotrophins support Bcl-2 gene expression, which inhibits intracellular apoptosis [180]. Thus, early diagnosis of neurodegeneration may allow for early treatment, which may help to prevent the disease from progressing further [181]. Inhibition of the N-methyl-D-aspartate (NMDA) receptor can prevent or postpone AD. The drugs memantine and namzaric, which act as antagonists for the NMDA receptor, are used to treat AD patients [182].
Bioactive molecules have been recognized for their valuable biological effects, including neuroprotective properties, such as the ability to regulate mitochondria in a way that is distinct from TMs [183]. Branco et al. (2018) found that the flavonoid-rich A. angustifolia bracts extract (AAE) has neuroprotective properties by restoring rotenone-induced mitochondrial complex I, inhibiting the formation of lipid peroxidation and neuronal ROS, and through over expression of NDUFS7 protein and NDUFV2 gene levels in human dopaminergic SH-SY5Y cells [43]. Bark extract of P. pinaster shows protective effects against oxidative hemolysis induced by H2O2, the formation of thiobarbituric acid reactive products and lipid peroxidation [184]. In addition, it prevents oxidative damage to many proteins aggregation and may lessen the risk of several NDs, such as AD, PD and HD [185]. The neuro-protective potential of various conifer spp. crude extracts is summarized in Table 5.

4.2.5. Alzheimer’s Disease (AD)

AD is a common neurodegenerative disease that affects 80% of the elderly population, accounting for about half of all dementia cases and ultimately results in death [186]. Its symptoms include failure to learn, gradual memory loss, and deterioration in behavior and neuronal function [187]. Regarding treatment, only five approved treatment options are licensed in the European Union for the treatment of AD, including rivastigmine, donepezil (cholinesterase inhibitors (ChEIs), galantamine, and memantine (NMDAR antagonist) [188]. An antimitotic agent paclitaxel widely used for the treatment of lung, ovarian and breast cancer has also been investigated as a possible treatment for AD [189]. It is mainly effective in the treatment of tauopathies, which are disorders caused by mutations in the tau protein, which is abundant in central nervous system (CNS) cells and acts by stabilizing microtubules [190]. The consumption of polyphenol-rich foods or beverages has been related to the prevention of AD in distinct studies [191]. The accumulation of amyloid-(A) in brain and leptomeningeal vessels causes cerebral amyloid angiopathy (CAA), which is also a central component of neuritic plaques in AD amyloid-(A) and has been related to the pathogenesis of two of the most common forms of dementia: AD and CAA. As a result, Aβ should be a top priority in the treatment of these diseases, which currently have no effective therapies [192]. Taxifolin, an antioxidant and anti-glycation flavonoid, reduces Aβ aggregation and its accumulation in the cerebrovascular system. In vitro studies have shown that taxifolin facilitates Aβ clearance in the brain, prevents Aβ fibril formation and CAA cognitive loss, and increases cerebral blood flow [193]. The methanol extract of P. roxburghii bark contains bioactive compounds, such as quercetin and gallic acid, which play important roles in neuroprotection by reversing mitochondrial dysfunction, free radical formation, and improving memory and cognition in rats, as well as reducing oxidative stress by improving acetylcholine levels. Furthermore, anti-AD activity has been documented in Pinus species, such as P. halepensis and P. massoniana [194]. Piceatannol, a compound derived from pine bark, has proven to be effective in preventing AD [195]. Resveratrol (RV), a stilbenoid, protects neurons from oxidative damage in a variety of ways, such as lowering lipid peroxidation and increasing intracellular antioxidant levels including antioxidant enzymes catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme oxygenase 1 (HO-1) [196]. In this way, RV acts as an anti-AD agent by reducing neuroinflammation, inhibiting Aβ-plaque formation and tauopathy, and as a result inhibits neuronal death and improves memory [197]. Pycnogenol derived from P. pinaster bark has antioxidant, anti-inflammatory, and neuroprotective properties, including inhibition of amyloid-induced neuron apoptosis [198]. When the effect of pycnogenol was investigated in AD-related pathology in a β-amyloidosis mouse model, a decline in plaque numbers was found, while no changes were reported in the soluble β-amyloidosis levels, astrocytes, neurons, microglia, myelination pattern, morphology of axons and the gene expression of APP-processing enzymes [199]. Hence, it is suggested that pycnogenol has potential use in the prevention or in early stages of AD and mild cognitive impairment (MCI) [200]. Table 5 summarizes the neuroprotective potential of different conifers’ phytochemicals in AD.

4.2.6. Parkinson’s Disease

PD is second to AD in terms of the most prevalent progressive ND, with an estimated global prevalence of over 10,000,000 cases [201]. The selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) leads to PD. Briefly, PD occurs due to oxidative stress, dysfunction of mitochondrial complex-1, oxidative cell damage, neuronal excitotoxicity, calcium homeostasis, apoptosis, distressed energy metabolism, inflammation and protein aggregation, such as a-synuclein, apoptosis, and interaction between genetic and environmental causes [202]. Due to uncoordinated mouth and throat movements, PD causes bradykinesia, muscle rigidity, rest tremor, and the loss of postural control, as well as certain secondary symptoms, such as dementia, sialorrhea, soft voice, and trouble swallowing [203,204]. Oxidative stress generates ROS that causes oxidative damage, such as 4-hydroxynonenal (HNE), 26S proteasome and interferes with dopamine metabolism leading to PD [85]. Changes in protein ubiquitination and degradation have recently been related to dopaminergic cell death in PD [205]. Presynaptic protein α-synuclein (α-syn) influences the release of neurotransmitters from synaptic vesicles in the brain [206]. Currently, the treatment of PD includes drugs such as L-DOPA, which is catalyzed primarily by dopa decarboxylase in the brain, and some others such as ropinirole, selegiline, and rasagiline. Ropinirole has some adverse effects, including ankle oedema, vomiting, nausea, hypotension, insomnia, weight loss, hallucinations, psychosis, arrhythmia, dry mouth, nightmares, persistent diarrhea, somnolence and constipation, limiting their clinical applications [207]. As a result, the focus of rising interest in alternative treatments for ND, such as PD, has turned to natural products, which can provide alternatives due to their high effectiveness and few side effects [208]. Many plant extracts tend to stop α-syn from oligomerization and fibrillation, which is an emerging therapeutic mechanism in PD [183]. Methanol extract of J. communis at doses of 100 and 200 mg/kg was found to be effective in reducing catalepsy, enhancing locomotor activity (actophotometer), and increasing the level of reduced glutathione (GSH), protein level and muscle activity in rats [209]. In an in vitro study on Fisher F344 rats, Zhang et al. (2010) discovered that RV protect dopaminergic neurons from damage caused by MPP+, 6-OHDA, and also show efficacy against lipopolysaccharide-induced neurotoxicity by inhibiting nuclear factor kappa B (NF-κB) signaling and microglial activation [210].

4.2.7. Insomnia

Insomnia is a chronically debilitating disease that has become increasingly common, posing immense health and economic challenges for both individuals and the community [211]. Trouble falling asleep, staying asleep, fragmented sleep (repeatedly waking up at night or waking up early in the morning) are all symptoms of this condition [212]. While behavioral therapy, psychotherapy and light therapy have all been used to treat insomnia, the most common medications for insomnia are hypnotic drugs that target GABAA-benzodiazepine (BZD) receptors, such as diazepam and zolpidem [213]. However, several side effects have been identified, including cognitive impairment, resistance, headaches, nausea, and rebound insomnia [214,215]. Methanol extract of A. webbiana leaves showed potent synergistic effect in mice at dose of 100, 150, and 200 mg/kg, with sleep-inducing sedative drugs, diazepam (6 mg/kg), pentobarbitone sodium (50 mg/kg) and propylene glycol [157]. In addition, the major monoterpenoid components present in Pinus spp., α-pinene and 3-carene, have been reported to have hypnotic effects through GABAA-BZD receptors. 3-carene increases the length of sleep in mice given pentobarbital-induced sleep drugs by binding to the BZD site of the GABAA-BZD receptor α1 and ϒ2 [216].

5. Other Activities

5.1. Antidiabetic Activity

Diabetes mellitus is one of the world’s most serious health issues, with a rising prevalence and mortality rate [217]. Insufficiency in blood sugar control has significant health implications. Anti-diabetic medications are successful, but they come with unwanted side effects. Medicinal plants, on the other hand, can act as an additional reservoir of anti-diabetic agents [218]. Insulin and synthetic oral drugs hypoglycemic drugs are the most commonly used treatments for diabetes, despite the fact that they do not fully reverse the disease’s complications and have severe side effects. This is the driving force behind the search for new anti-diabetic agents [219]. After six years of treatment, sulfonylureas are expected to lose effectiveness in 44% of patients, while glucose-lowering drugs have been stated to be unable to control hyperlipidemia [220]. Nonetheless, the quest for newer antidiabetic drugs from natural sources continues due to many drawbacks associated with the use of current synthetic antidiabetic drugs [221].
Many plants have long been known to be a significant source of effective antidiabetic drugs in developing countries, especially to reduce the cost of conventional treatments [217]. Phytoconstituents, such as terpenoids, flavonoids, alkaloids, carotenoids, saponins, glycosides, which have antidiabetic effects, are now used to treat diseases such as diabetes [219,222]. Indeed, the number of people living with diabetes is rising, stoking concerns among medical professionals and the public. Despite the availability of antidiabetic medications in the market, medicinal plants are also effective [217]. The Araucaria, Cedrus, Juniperus, Pinus, Thuja, and Taxus genera have all been studied for their antidiabetic, antihyperglycemic, and hypoglycemic properties, as well as their ability to inhibit α-amylase and α-glucosidase and shown in Table 6.
In vitro experiments exhibited that the ethanol extract of P. halepensis bark had a greater inhibitory effect on the enzymes involved in diabetes (α-amylase and α-glucosidase) with IC50 values of 234.26 and 7.97 µg/mL, respectively [151]. Piceatannol is a phytochemical that has antidiabetic properties. Piceatannol, a resveratrol analogue, restores palmitic acid-induced disruption of insulin signaling and endothelial NO production in human endothelial cells by activating anti-inflammatory and antioxidant mechanisms (HO-1) [223]. According to Vallianou et al. (2013), the antihyperglycemic property of resveratrol appears by increasing the glucose transporter activity that occurs in the plasma membrane; the results indicate that the key antihyperglycemic action effects of resveratrol are due to the SIRT1 activation and AMPK (5’ AMP-activated protein kinase) [224]. RV antidiabetic activity is linked to its ability to increase AMPK and SIRT1 expression/activity in different tissues of diabetic subjects [225]. The multi-target effects of RV against diabetes were well-defined by Bagul and Banerjee, 2015, who underlined an improvement in insulin sensitivity and GLUT-4 translocation, while oxidative stress was reduced, carbohydrate-metabolizing enzymes were regulated, SIRT1 and AMPK were activated, and adipogenic genes were decreased [226]. As a result, lowering glucose levels by inhibiting enzyme activity is an effective method for treating hyperglycemia through using natural products.

5.2. Anticonvulsant Activity

Epilepsy is a neurological condition that affects people of all ages all over the world. The side effects of antiepileptic drugs and their connection to oxidative stress have prompted researchers to look for new medications that are less expensive and that have fewer side effects [227]. Several natural compounds derived from various conifer species have shown good anticonvulsant properties in animal models [228]. In India, extracts of C. deodara wood and P. roxburghii bark have historically been used to treat neurological disorders. In this analysis, the anticonvulsant activity of 3,4-bis(3,4-dimethoxyphenyl)furan-2,5-dione (BDFD) isolated from the ethanol extract of C. deodara and quercetin, chlorogenic acid, and rutin isolated from the ethanol extract of P. roxburghii bark were assessed in mice, and the results demonstrate modulation in the function of glutamate receptors by enhancing inhibitory GABA minergic neurotransmission [228,229]. Hinokiol, a neuromodulatory compound isolated from Taiwania cryptomerioides, affects NG108-15 cells and rat hippocampal CA1 neurons or neuronal ion channel activities by inhibiting voltage-gated Na(+) channels (VGSC) [230]. Lectins, normally a glycoprotein extracted from seed of A. angustifolia, had an antiseizure effect in strychnine and pentylenetetrazole-induced seizure models, revealing positive effects in the activation of glycinergic and GABAergic systems, respectively, and caused a reduction in animal movements [231].

5.3. Analgesic Activity

Analgesia/pain is an intense, ill-defined feeling triggered by a stimulus (external/internal); it is the most significant symptom that serves as an alarm signal and is mainly defensive in nature [232]. Bradykinin, tumor necrosis factor (TNF), and ILs cause analgesia by blocking the pain nerve sensitizing pathway [233]. An analgesic is a drug that relieves pain by acting on pain mechanisms in the CNS or in the peripheral nervous system (PNS) without affecting consciousness [234]. Even after new advances in pain therapies, healthcare professionals still need safe, reliable, and effective analgesic drugs to treat a variety of painful conditions, especially chronic pain. Based on its traditional medicinal uses, isolated T. wallichiana constituents are widely explored for analgesic purposes [22]. Indeed, the analgesic activity of C. deodara methanol bark extract was observed in Albino rats with acetic acid-induced writhing and found that it had a major analgesic effect, with 55.8% defense at a dose of 100 mg/kg [159]. In the acetic acid-induced writhing and hot plate model, Cupressus flavanone (CUF) demonstrated significant analgesic activity. At the three CUF doses used, 160 mg/kg in 120 min prevented PG synthesis and writhing response in mice at a rate of 25, 48, and 62%, respectively [46].

5.4. Antinociceptive Activity

Heartwood ethanol extract of T. baccata taxoids and lignin derivative compounds exhibited potent antinociceptive activity against p-benzoquinone-induced abdominal contractions in mice [29].

5.5. Antimicrobial Activity

Coniferous tree extracts are attracting intensified interest among scientific communities due to their possible applications in food, medicine, and cosmetics. Among conifers spp., various extracts have recently been identified as a significant source of bioactives with antimicrobial potential, as shown in Supplementary Materials Table S1.
Table 5. Conifers’ phytochemicals demonstrating neuroprotective potential in vitro and in vivo.
Table 5. Conifers’ phytochemicals demonstrating neuroprotective potential in vitro and in vivo.
Conifers spp.Compounds with Neuroprotective PotentialModelEffective ConcentrationRelevant BioactivitiesReference
Abies holophyllaHolophyllin-DC6 glioma cells20 μMDiterpenes compound holophyllin D shows neuroprotective potential in C6 glioma cells by inducing nerve growth factor[25]
Araucara angustifoliaCatechin, epicatechin and rutinRat10 mg/mLAAE has antioxidant and neuroprotective properties as it decreases the TBARS levels, CAT activity and NO production in the hippocampus region of the brain in rats.[235]
A. angustifoliaCatechin, epicatechin, rutin, quercetin and apigeninhuman dopaminergic SH-SY5Y cells5 μg/mLDecrease in the production of neuron (ROS) and lipid peroxidation.[43]
A. angustifoliaQuercetincockroach200–400 μg/gNeurotoxicity modulates the behavior of insects by altering the dopaminergic pathways, as quercetin has the ability to induce selective inhibitory actions on NMDA and GABA receptors and inhibit the enzyme acetylcholinesterase (AChE)[236]
Cedrus deodaraCedrinPC12 cells0.1, 1 and 10 μMPC12 cells injured by amyloid β1–42 can be improved by cedrin. Cedrin can reduce (ROS) overproduction, enhance the activity of SOD and decrease MDA content and inhibition of oxidative stress, improvement of mitochondrial dysfunction and suppression of apoptosis in PC12 cells[237]
Metasequoia glyptostroboidesGallic acid, rutin, myricetin, kaempferol, quercitrin, epigallocatechin, epicatechin gallate epigallocatechin gallate and caffeic acidNeuronal PC12 cells2 mg/mLThe extracts effectively reduced the hydrogen peroxide-induced lipid peroxidation in neuronal PC12 cells by decreasing intracellular ROS accumulation[49]
Pinus densifloraCatechin, quercetin dehydrate, astragalin and kaempferolMice50–100 mg/kgCatechin displayed a potential effect protecting mouse brains from oxidative damage via the improvement of the antioxidant capacities of TAC, the GSH-redox system, SOD and CAT in the hippocampus region as well as the inactivation of cytokines such as NF-kB in pyramidal cells of the hippocampal CA1 region, while PNE shows antiamnesic properties and effects in Alzheimer’s, as it attenuated the increase in serum corticosterone level and up-regulation of GR hippocampal gene expression[238,239]
P. eldaricaNeedle extractMice50 mg/kgAlkanes, sterols, terpenoids, and quercetin, which is found in P. eldarica, help in inducing sleep and alter the sleep–wake cycle partly via activation of GABA receptors[240]
P. massonianaPolyprenolsMice25 mg/kgPolyprenols significantly increased T-AOC, GSHPx, damaging peroxide components from cells in order to stop the lipid peroxidation chain reaction and avoid excessive hydrolysis to form NEP, MDA, SOD activity (remove free radicals) and β-site AβPP cleaving enzyme 1 (BACE1) expression, while NOS activity, MDA concentration, NO, concentration of Aβ1-42 and PS1 were reduced[241]
P. pinasterPycnogenol (PYC)Mice20 mg/kgIn the MPTP-induced mouse model, PYC could prevent dopaminergic neurons by reducing oxidative loads, suppressing glial cell activation, and inhibiting inflammatory responses[100,242]
P. roxburghiiQuercetin, rutin, gallic acidWistar albino100–300 mg/kgQuercetin and gallic acid, both present in stem bark, have been shown to inhibit neuronal toxicity and apoptosis by reversing mitochondrial dysfunction and free radical development[243]
Thuja occidentalisWater extractMice100 mg/kgCNS depressant activity, anticonvulsant and muscle relaxant activity[244]
Torreya nucifera,ArctigeninRat Cortical cells0.01 µM to 10.0 µM.Arctigenin significantly attenuated glutamate-induced neurotoxicity by inhibiting the binding of [3H]-kainate to its receptors[35]
T. semenPolyphenols, flavonoidsMice0–10 mg/mLTS increased the level of total glutathiones[245]
T-AOC—total antioxidative capacity; GSHPx—glutathione peroxidise; SOD—super oxide dismutase; NEP—neprilysin; MDA—malondialdehyde; NO—nitric oxide, NOS—nitric oxide synthase; PS1—presenilin 1, CAT—catalase.
Table 6. Antidiabetic activity of different conifer extracts.
Table 6. Antidiabetic activity of different conifer extracts.
Conifer spp.Part UsedCompoundsModelInduction of DiabetesDose. ConcEffectsReferences
Araucaria cunninghamiiSeedsGlucomannanAlbino wistar ratsStreptozotocin25 and 50 mg/kg
  • Glucomannan reduce blood glucose level due to presence of D-glucosyl and β-1, 4-linked D-mannosyl units
  • Decreases total cholesterol (TC) total glycerides (TG), high density lipoproteins cholesterol (HDL-C), very low-density lipoprotein cholesterol (VLDL-C) and low-density lipoprotein cholesterol (LDL-C)
Cedrus deodaraHeart woodFlavonoidsWistar albino ratAlloxan500 mg/kg
  • Reduction in blood sugar level from 49.79% within 21 days.
BerryFlavonoidsWistar ratStreptozotocin250 mg/kg
  • JCB extract have potential to increase the peripheral glucose absorption and plasma insulin levels
J. communisNRNRRatStreptozotocin-nicotinamide100–200 mg/kg
  • Reduction in blood glucose levels
  • Antihyperlipidemic activity in the form of the reduction in TG TC, LDL, and VLDL dose-dependently
J. oxycedrusLeavesLinolenic acid, oleic acidWistar-albino ratsStreptozotocin500 and 1000 mg/kg doses
  • Leaf extracts rich in unsaturated fatty acids responsible for activating PPAR ϒ receptors or increasing the release of insulin from beta cells of the pancreas to reduce glucose levels
Pinus gerardianaNutFlavonoidsRatAlloxan250, 500, and 750 mg/kg
  • Decrease the blood glucose level by inhibiting alpha-amylase enzyme activity
  • Antihyperlipidemic
P. halepensisBarkPhenolic compoundsRatGlucose250, 500 mg/kg
  • Stop enzymes (α-glucosidase and α-amylase) implicated in sugar metabolism antioxidant
P. pinasterBarkPhenolic compoundsNR IC50 (µg/mL) at PB 70% and PB 50%
  • PBEs ethanol extract at PB.70% and 50% shows higher α-amylase and β-glucosidases inhibitory activity, respectively
P. pinasterBarkPynogenolHumanNR100 mg
  • Reduce blood glucose level in blood
  • Elevated antioxidant defense mechanisms
P. roxburghiiBarkQuercetinNRAlpha amylase inhibitory activity100 μg/mL
  • Quercetin present in extract displayed significant enzyme inhibitory activity against α-amylase, with 49.6% inhibition.
P. roxburghiiBarkQuercetinRatAlloxan100, 300 and 500 mg/kg
  • Anti-hyperglycemic activity of P. roxburghii Sarg. extract increase the releasing of beta cell regeneration against alloxan induced free radicals
  • Antihyperlipidemic activity
Taxus cuspidataBranches and leavesWaterPolysaccharides Pe4 (arabinose, galactose, glucose, xylose, mannose)NR10–120 μg/mL
  • Pe4 showing good type 2 antidiabetic activity by inhibiting α-glucosidase
  • Inhibit human cervical cancer
NR—Not reported.
Conifer compounds act as antimicrobials because they have potential in degrading microbial cell walls: disruption to the cytoplasmic membrane and membrane proteins, cell leakage, cytoplasm coagulation, and proton motive force depletion are all examples of their inhibitory action [254]. The following is a list in descending order of the key bioactive compounds responsible for antimicrobial effects: ketones > alcohols > esters > hydrocarbons > aldehydes > ketones > alcohols > esters > hydrocarbons [255]. Terpenoid compounds (α-terpineol, δ--3-carene, geranyl acetate, borneol, α and β-pinene, limonene, α-terpinene, ϒ-terpinene, β-ocimene, bornyl acetate, 1,8-cineole, α-phellandrene, p-cymene, linalool, ϒ-muurolene, α-humulene, and cadinene) have been found to be responsible for antimicrobial activity [8,33]. Alkaloids, especially 1,6-dehydropinidine obtained from P. abies needle and bark, have recently been discovered to have antimicrobial activity against Streptococcus equi (MIC = 55 g/mL) [13]. Secoisolariciresinol, pinoresinol, eudesmin, lariciresinol, and lariciresinol-4-methyl ether isolated from A. araucana wood methanol extract have shown potent antibacterial and antifungal activity with a synergistic effect, enhancing their potency against bacteria and fungi [256]. Anti-herpes activity was found in hydroethanolic extract ethyl acetate (EA) and n-butanol (NB) fractions from A. angustifolia leaves, indicating that conifer spp. could have been used in folk medicine to treat viruses [45]. It has been reported that RV, piceatannol, hydroxystilbenes and isorhapontigenin are present in debarking water, a byproduct of debarking logs of P. abies, meaning that it has the potential to prevent the growth of a variety of fungi and may be used as a natural fungicide [257].

5.6. Larvicidal Activity

In recent years, there has been increased interest in secondary metabolites with potential larvicidal activity in a number of countries around the world [258]. Dengue fever, yellow fever, dengue hemorrhagic fever, malaria and chikungunya are the most severe diseases transmitted by mosquitoes. Aedes aegypti is one of the mosquito species involved in the transmission of such vector disease outbreaks [258,259]. Larvicidal activity has been documented in extracts of conifer spp. parts [260]. The mosquito control technique is determined by the larval stages (egg, larvae, pupae, and adult) of the target. Mosquito control methods include spraying chemical insecticides on adult mosquitoes or destroying mosquito larvae before they grow into adults, either by means of synthetic larvicides or by using botanical extracts as an alternative larvicide [258]. The use of these synthetic insecticides against mosquitoes creates insecticide resistance as well as multifarious problems, such as environmental pollution and poisonous hazards to human beings [261]. These plant-oriented natural products are eco-friendly in nature and are preferred for use against larvae over other synthetic insecticides [262]. Based on mortality, the ethanol extract of J. procera and T. orientalis leaves has potential against Anopheles arabiensis, A. stephensi and Culex quinquefasciatus larvae [260,263]. It also has been found that C. sempervirens petroleum ether leaves extract shows a toxic effect on Musca domestica larva and also causes a decrease in the production of eggs and fecundity, as well as inducing sterility in both males and females [264]. Ethanol extract of Pinus caribaea and P. merkusii leaves and bark exhibited the highest mortality in the larvae of A. aegypti, a vector responsible for dengue fever transmission [265].

5.7. Cardiovascular Diseases

The rate of death due to cardiovascular diseases is quite high. Several medications are available to treat cardiovascular disorders and their complications. The general public has come to recognize the use of functional foods or dietary supplements to treat cardiovascular diseases [266]. A study reported that pycnogenol supplementation regulates the circulation in blood vessels, and reduces mild hypertension, cardiovascular diseases and platelet aggregation stimulated by smoking [267]. RV protects the heart by inhibiting platelet aggregation, thromboxane A2 formation (vasodilator effect), and Cox-1 peroxidase reactions [268]. In addition, low doses of RV (such as those present in the average diet) have been shown to have cardioprotective effects [269]. Cardiovascular disorders are common in both developing and developed countries. Piceatannol is intended to help to prevent cardiovascular disorders, including arrhythmia, high cholesterol, angiogenesis, and atherosclerosis [266]. Piceatannol pretreatment decreases cardiac hypertrophy, as measured by hypertrophy marker expression levels, cross-sectional area, and heart weight/body weight ratio. It also prevents lentiviral GATA-6-induced cardiac hypertrophy [270].

6. Clinical Trials

Clinical trials using extracts from conifer species in humans are limited. Only a few studies have reported the use of conifer spp. extracts in humans for inflammation and cardiovascular issues. A randomized 10-day, double-blind clinical trial was conducted on traumatic brain injury (TBI) patients. A pycnogenol supplement (OLIGOPIN) was orally administered with an oral dose of 150 mg per day, conducted in 60 people, with 30 control (Placebo) and 30 taking the PYC supplement, and it was found that PYC is effective in reducing inflammation and oxidative stress in TBI patients by increasing the level of pro-inflammatory cytokines, e.g., IL-6, TNF-α, IL-1β, and C-reactive protein (CRP) [271]. Another pilot study with a length of 12 weeks was conducted with Enzogenol® at an oral dose of 480 mg/day in 26 healthy people aged between 55 and 75 years. Some significant results have been published, such as beneficial changes in anthropometric data, a reduction in unnecessary body fat, vascular and plasma rheological indices, with a reduction in blood pressure and cardiovascular-related problems [272]. Nowadays, many products such as supplements, gels, creams, lotions, capsules, tablets, ointments formed from conifers’ bark, and needle powder are sold commercially. Table 7 describes the main characteristics of these products.
Table 7. Conifer-derived commercially available products sold on the global market.
Table 7. Conifer-derived commercially available products sold on the global market.
PlantPart UsedTrade NamePhytochemicals CompositionFormulationDose/DurationProduct
Pinus pinasterBarkPycnogenolCatechin, taxifolin, procyanidins, caffeic, p-hydroxybenzoic, ferulic, acids Tablets, liquids, chewing gums, gels, ointments, capsules or lotions 150 mg/day for 6 months Molecules 26 03005 i001
P. pinasterBarkOligopinCaffeic acid, catechin, epicatechin, taxifolin and ferulic acid Capsules 150 mg for 10 days Molecules 26 03005 i002
P. radiataBarkEnzogenol Flavanoids, proanthocyanidins Tablets480–960 mg/day for 5–6 months Molecules 26 03005 i003
Picea abiesNeedlesRopren Flavanoids Tablets, capsules, lotions 8.6 mg/kg for 28 days Molecules 26 03005 i004
Taxus brevifoliaBarkTaxolPaclitaxel Injections 30 mg/m2 every 3 weeks Molecules 26 03005 i005
P. massionaBarkNot foundPolyphenols, flavanoids, proanthocyanidins Capsules 1 capsule daily Molecules 26 03005 i006

7. Phytotoxic Effects of Conifer Extract

Despite all of the advances stated so far, toxicity studies are required to know the effective doses that could be administered subsequently, as well as to depict the potential clinical signs elicited by the plant material [273]. Few toxicological studies have been reported on T. baccata, P. contorta and J. communis needles. A study was performed on a sample collected from a fatal case of a 22-year-old man, which revealed the presence of taxol A, diterpenoids such as monoacetyltaxine, and cardiotoxic compounds, such as 10-deacetylbaccatin III and taxine B. These compounds bind to calcium channels in cardiac myocytes, causing nausea, seizures, vomiting, dizziness, several cardiovascular effects, including bradycardia, and leading to ventricular tachycardia with severe ventricular arrhythmias, ventricular fibrillation and abdominal pain [274]. In another study, it was found that pine and juniper needles at an oral gavage dose of 62–245 mg/day in cattle have an abortifacient effect due to the presence of isocupressic acid in high doses [271]. Therefore, it is unsafe to feed pine and juniper needles to gravid cattle.

8. Conclusion and Future Trends

In this review, we have discussed the traditional and pharmacological uses of various conifers’ extracts against diabetes, neurological disorders, inflammation, and cancer. The phytochemical constituents present in conifer extracts are nontoxic at therapeutic levels, with polyphenolic compounds having significant biological activities. Stilbenes, terpenes, alkaloids, lignins and flavanoids, such as quercetin, rutin, resveratrol, and the compounds PYC and enzogenol, are the phytochemical components of conifer extracts reported to have sedative, antidiabetic, anticancer and anesthetic effects. In addition, phytochemicals present in conifer extracts assist in the regulation of glucose and lipid metabolism, insulin secretion, stimulating β cells, the NF-kB signaling pathway, the inhibition of gluconeogenic enzymes, ROS protective action as well as targeting and modulating cytokines which affect neuron cells and reduce oxidative stress. In this way, conifers’ phytochemicals are used as an alternative to synthetic drugs and can be to a greater extent in the future, as they can be helpful in the formulation of new drugs. Without a doubt, conifers’ phytochemicals are the natural sources of future drugs; in the field of drug discovery, a large number studies into phytochemicals are still required. More efforts are needed to investigate and assess the clinical potential and molecular characterization of medicinal compounds with the help of databases and interdisciplinary group efforts.

Supplementary Materials

The following are available online, Table S1: Antiviral, antibacterial and antifungal activity of different conifers’ extracts.

Author Contributions

Conceptualization, A.S.S., P.B., N.C.-M. and K.K.; Writing—review, K.B., R.S. (Rohit Sharma), R.S. (Ruchi Sharma), D.S.D. and M.A.A.; Editing, M.A., E.N., K.M., B.S., N.K.U., M.N.; Funding acquisition, N.C.-M., K.M. and K.K. All authors have read and agreed to the published version of the manuscript.


This research was funded by University of Hradec Kralove (Faculty of Science VT 2019-2021).


We acknowledge the University of Hradec Kralove (Faculty of Science VT2019-2021) for financial support.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Mustafa, G.; Arif, R.; Atta, A.; Sharif, S.; Jamil, A. Bioactive Compounds from Medicinal Plants and Their Importance in Drug Discovery in Pakistan. Matrix Sci. Pharma 2017, 1, 17–26. [Google Scholar] [CrossRef]
  2. Abdel-Razek, A.S.; El-Naggar, M.E.; Allam, A.; Morsy, O.M.; Othman, S.I. Microbial natural products in drug discovery. Processes 2020, 8, 470. [Google Scholar] [CrossRef][Green Version]
  3. Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The traditional medicine and modern medicine from natural products. Molecules 2016, 21, 559. [Google Scholar] [CrossRef] [PubMed][Green Version]
  4. Nisar, B.; Sultan, A.; Rubab, S.L. Comparison of Medicinally Important Natural Products versus Synthetic Drugs-A Short Commentary. Nat. Prod. Chem. Res. 2018, 06, 308. [Google Scholar] [CrossRef]
  5. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981–2002. J. Nat. Prod. 2003, 66, 1022–1037. [Google Scholar] [CrossRef]
  6. Galm, U.; Shen, B. Natural Product Drug Discovery: The Times Have Never Been Better. Chem. Biol. 2007, 14, 1098–1104. [Google Scholar] [CrossRef][Green Version]
  7. Akaberi, M.; Boghrati, Z.; Amiri, M.S.; Khayyat, M.H.; Emami, S.A. A Review of Conifers in Iran: Chemistry, Biology and their Importance in Traditional and Modern Medicine. Curr. Pharm. Des. 2020, 26, 1584–1613. [Google Scholar] [CrossRef] [PubMed]
  8. Bhardwaj, K.; Islam, M.T.; Jayasena, V.; Sharma, B.; Sharma, S.; Sharma, P.; Kuča, K.; Bhardwaj, P. Review on essential oils, chemical composition, extraction, and utilization of some conifers in Northwestern Himalayas. Phyther. Res. 2020, 34, 2889–2910. [Google Scholar] [CrossRef]
  9. Bhardwaj, K.; Dhanjal, D.S.; Sharma, A.; Nepovimova, E.; Kalia, A.; Thakur, S.; Bhardwaj, S.; Chopra, C.; Singh, R.; Verma, R.; et al. Conifer-derived metallic nanoparticles: Green synthesis and biological applications. Int. J. Mol. Sci. 2020, 21, 9028. [Google Scholar] [CrossRef]
  10. Conifers. Available online: (accessed on 15 March 2021).
  11. Farjon, A. The Kew Review Conifers of the World. Kew Bull. 2018, 5974, 1–16. [Google Scholar] [CrossRef][Green Version]
  12. Kopaczyk, J.M.; Warguła, J.; Jelonek, T. The variability of terpenes in conifers under developmental and environmental stimuli. Environ. Exp. Bot. 2020, 180, 104197. [Google Scholar] [CrossRef]
  13. Virjamo, V.; Fyhrquist, P.; Koskinen, A.; Lavola, A.; Nissinen, K.; Julkunen-Tiitto, R. 1,6-Dehydropinidine Is an Abundant Compound in Picea abies (Pinaceae) Sprouts and 1,6-Dehydropinidine Fraction Shows Antibacterial Activity against Streptococcus equi Subsp. equi. Molecules 2020, 25, 4558. [Google Scholar] [CrossRef] [PubMed]
  14. Mill, R.R.; Chase, M.W. A new classification and linear sequence of extant gymnosperms. Phytotaxa 2011, 19, 55–70. [Google Scholar]
  15. Sharma, A.; Sharma, L.; Goyal, R. A review on himalayan pine species: Ethnopharmacological, phytochemical and pharmacological aspects. Pharmacogn. J. 2018, 10, 611–619. [Google Scholar] [CrossRef][Green Version]
  16. Tiberi, R.; Niccoli, A.; Curini, M.; Epifano, F.; Marcotullio, M.C.; Rosati, O. The role of the monoterpene composition in Pinus spp. needles, in host selection by the pine processionary caterpillar, Thaumetopoea pityocampa. Phytoparasitica 1999, 27, 263–272. [Google Scholar] [CrossRef]
  17. Naser, B.; Bodinet, C.; Tegtmeier, M.; Lindequist, U. Thuja occidentalis (Arbor vitae): A review of its pharmaceutical, pharmacological and clinical properties. Evid. Based Complement. Altern. Med. 2005, 2, 69–78. [Google Scholar] [CrossRef][Green Version]
  18. St-Pierre, A.; Blondeau, D.; Bourdeau, N.; Bley, J.; Desgagné-Penix, I. Chemical Composition of Black Spruce (Picea mariana) Bark Extracts and Their Potential as Natural Disinfectant. Ind. Biotechnol. 2019, 15, 219–231. [Google Scholar] [CrossRef][Green Version]
  19. Rafieian-kopaei, M.; Suleimani dehkordi, I.; Ghanadian, M.; Shokrollahi, A.; Aghaei, M.; Ayatollahi, S.A.; Choudhary, M.I. Bioactivity-guided isolation of new antiproliferative compounds from Juniperus foetidissima Willd. Nat. Prod. Res. 2016, 30, 1927–1933. [Google Scholar] [CrossRef]
  20. Barnawi, I.O.; Nasr, F.A.; Noman, O.M.; Alqahtani, A.S.; Al-Zharani, M.; Alotaibi, A.A.; Daradka, H.M.; Al-Mishari, A.A.; Alobaid, W.A.; Alqahtani, A.; et al. Induction of apoptosis and cell cycle arrest by chloroform fraction of Juniperus phoenicea and chemical constituents analysis. Open Chem. 2021, 19, 119–127. [Google Scholar] [CrossRef]
  21. Osuna-Torres, L.; García-Martí, X.; Ventura-Zapata, E.; López-Upton, J.; Zamilpa-Alvarez, A.; González-Cortazar, M.; Herrera-Ruiz, M.; Tapia-Barrera, N. Taxus globosa Schltdl. (Mexican yew) and Taxus baccata L. (European yew): Intra and interspecies analysis of taxol content and biological activity according to different sources. For. Syst. 2015, 24, 16. [Google Scholar] [CrossRef][Green Version]
  22. Qayum, M.; Nisar, M.; Shah, M.R.; Adhikari, A.; Kaleem, W.A.; Khan, I.; Khan, N.; Gul, F.; Khan, I.A.; Zia-Ul-Haq, M.; et al. Analgesic and antiinflammatory activities of taxoids from Taxus wallichiana Zucc. Phyther. Res. 2012, 26, 552–556. [Google Scholar] [CrossRef] [PubMed]
  23. Kusumoto, N.; Aburai, N.; Ashitani, T.; Takahashi, K.; Kimura, K. Pharmacological Prospects of Oxygenated Abietane-Type Diterpenoids from Taxodium distichum Cones. Adv. Biol. Chem. 2014, 04, 109–115. [Google Scholar] [CrossRef][Green Version]
  24. Muto, N.; Tomokuni, T.; Haramoto, M.; Tatemoto, H.; Nakanishi, T.; Inatomi, Y.; Murata, H.; Inada, A. Isolation of apoptosis- and differentiation-inducing substances toward human promyelocytic leukemia HL-60 cells from leaves of Juniperus taxifolia. Biosci. Biotechnol. Biochem. 2008, 72, 477–484. [Google Scholar] [CrossRef][Green Version]
  25. Kim, C.S.; Subedi, L.; Kim, S.Y.; Choi, S.U.; Kim, K.H.; Lee, K.R. Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities. J. Nat. Prod. 2016, 79, 387–394. [Google Scholar] [CrossRef] [PubMed]
  26. Bajpai, V.K.; Sharma, A.; Kang, S.C.; Baek, K.H. Antioxidant, lipid peroxidation inhibition and free radical scavenging efficacy of a diterpenoid compound sugiol isolated from Metasequoia glyptostroboides. Asian Pac. J. Trop. Med. 2014, 7, 9–15. [Google Scholar] [CrossRef][Green Version]
  27. Tavares, W.; Seca, A. The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites. Medicines 2018, 5, 81. [Google Scholar] [CrossRef] [PubMed][Green Version]
  28. Tawara, J.N.; Blokhin, A.; Foderaro, T.A.; Stermitz, F.R.; Hope, H. Toxic Piperidine Alkaloids from Pine (Pinus) and Spruce (Picea) Trees. New Structures and a Biosynthetic Hypothesis. J. Org. Chem. 1993, 58, 4813–4818. [Google Scholar] [CrossRef]
  29. Küpeli, E.; Erdemoǧlu, N.; Yeşilada, E.; Şener, B. Anti-inflammatory and antinociceptive activity of taxoids and lignans from the heartwood of Taxus baccata L. J. Ethnopharmacol. 2003, 89, 265–270. [Google Scholar] [CrossRef]
  30. Juyal, D.; Thawani, V.; Thaledi, S.; Joshi, M. Ethnomedical properties of Taxus wallichiana Zucc. (Himalayan yew). J. Tradit. Complement. Med. 2014, 4, 159–161. [Google Scholar] [CrossRef][Green Version]
  31. Hafezi, K.; Hemmati, A.A.; Abbaszadeh, H.; Valizadeh, A.; Makvandi, M. Anticancer activity and molecular mechanisms of α-conidendrin, a polyphenolic compound present in Taxus yunnanensis, on human breast cancer cell lines. Phyther. Res. 2020, 34, 1397–1408. [Google Scholar] [CrossRef]
  32. Ivanova, D.I.; Tashev, A.N.; Nedialkov, P.T.; Ilieva, Y.E.; Atanassova, T.N.; Olech, M.; Nowak, R.; Angelov, G.; Tsvetanova, F.V.; Iliev, I.A.; et al. Antioxidant and antiproliferative activity of Juniperus L. Species of Bulgarian and foreign origin and their anticancer metabolite identification. Bulg. Chem. Commun. 2018, 50, 144–150. [Google Scholar]
  33. Kanchan, B.; Prerna, B.; Simran, K. Medicinal value of secondary metabolites of pines grown in Himalayan region of India. Res. J. Biotechnol. 2020, 15, 131–140. [Google Scholar]
  34. Singh, S.K.; Shanmugavel, M.; Kampasi, H.; Singh, R.; Mondhe, D.M.; Rao, J.M.; Adwankar, M.K.; Saxena, A.K.; Qazi, G.N. Chemically standardized isolates from Cedrus deodara stem wood having anticancer activity. Planta Med. 2007, 73, 519–526. [Google Scholar] [CrossRef]
  35. Jang, Y.P.; Kim, S.R.; Choi, Y.H.; Kim, J.; Kim, S.G.; Markelonis, G.J.; Oh, T.H.; Kim, Y.C. Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor. J. Neurosci. Res. 2002, 68, 233–240. [Google Scholar] [CrossRef] [PubMed]
  36. Asmi, K.S.; Lakshmi, T.; Balusamy, S.R.; Parameswari, R. Therapeutic aspects of taxifolin—An update. J. Adv. Pharm. Educ. Res. 2017, 7, 187–189. [Google Scholar]
  37. Hammerbacher, A.; Kandasamy, D.; Ullah, C.; Schmidt, A.; Wright, L.P.; Gershenzon, J. Flavanone-3-hydroxylase plays an important role in the biosynthesis of spruce phenolic defenses against bark beetles and their fungal associates. Front. Plant Sci. 2019, 10, 1–15. [Google Scholar] [CrossRef] [PubMed]
  38. Michael, H.N.; Awad, H.M.; El-Sayed, N.H.; Paré, P.W. Chemical and antioxidant investigations: Norfolk pine needles (Araucaria excelsa). Pharm. Biol. 2010, 48, 534–538. [Google Scholar] [CrossRef]
  39. Ferreira-Santos, P.; Genisheva, Z.; Botelho, C.; Santos, J.; Ramos, C.; Teixeira, J.A.; Rocha, C.M.R. Unravelling the biological potential of Pinus pinaster bark extracts. Antioxidants 2020, 9, 334. [Google Scholar] [CrossRef][Green Version]
  40. Gascón, S.; Jiménez-Moreno, N.; Jiménez, S.; Quero, J.; Rodríguez-Yoldi, M.J.; Ancín-Azpilicueta, C. Nutraceutical composition of three pine bark extracts and their antiproliferative effect on Caco-2 cells. J. Funct. Foods 2018, 48, 420–429. [Google Scholar] [CrossRef]
  41. Dziedzinski, M.; Kobus-Cisowska, J.; Szymanowska, D.; Stuper-Szablewska, K.; Baranowska, M. Identification of polyphenols from coniferous shoots as natural antioxidants and antimicrobial compounds. Molecules 2020, 25, 3527. [Google Scholar] [CrossRef]
  42. Fierascu, I.; Ungureanu, C.; Avramescu, S.M.; Cimpeanu, C.; Georgescu, M.I.; Fierascu, R.C.; Ortan, A.; Sutan, A.N.; Anuta, V.; Zanfirescu, A.; et al. Genoprotective, antioxidant, antifungal and anti-inflammatory evaluation of hydroalcoholic extract of wild-growing Juniperus communis L. (Cupressaceae) native to Romanian southern sub-Carpathian hills. BMC Complement. Altern. Med. 2018, 18, 1–15. [Google Scholar] [CrossRef] [PubMed][Green Version]
  43. Branco, C.S.; Duong, A.; Machado, A.K.; Wu, A.; Scola, G.; Andreazza, A.C.; Salvador, M. Araucaria angustifolia (Bertol.) Kuntze has neuroprotective action through mitochondrial modulation in dopaminergic SH-SY5Y cells. Mol. Biol. Rep. 2019, 46, 6013–6025. [Google Scholar] [CrossRef]
  44. Nisar, M.; Khan, I.; Ahmad, B.; Ali, I.; Ahmad, W.; Choudhary, M.I. Antifungal and antibacterial activities of Taxus wallichiana Zucc. J. Enzym. Inhib. Med. Chem. 2008, 23, 256–260. [Google Scholar] [CrossRef][Green Version]
  45. Freitas, A.M.; Almeida, M.T.R.; Andrighetti-Fröhner, C.R.; Cardozo, F.T.G.S.; Barardi, C.R.M.; Farias, M.R.; Simões, C.M.O. Antiviral activity-guided fractionation from Araucaria angustifolia leaves extract. J. Ethnopharmacol. 2009, 126, 512–517. [Google Scholar] [CrossRef]
  46. Al-Sayed, E.; Gad, H.A.; El-Shazly, M.; Abdel-Daim, M.M.; Nasser Singab, A. Anti-inflammatory and analgesic activities of cupressuflavone from Cupressus macrocarpa: Impact on pro-inflammatory mediators. Drug Dev. Res. 2018, 79, 22–28. [Google Scholar] [CrossRef] [PubMed]
  47. Ferrentino, G.; Haman, N.; Morozova, K.; Tonon, G.; Scampicchio, M. Phenolic compounds extracted from spruce (Picea abies) by supercritical carbon dioxide as antimicrobial agents against gram-positive bacteria assessed by isothermal calorimetry. J. Therm. Anal. Calorim. 2020. [Google Scholar] [CrossRef]
  48. Hoon, L.Y.; Choo, C.; Watawana, M.I.; Jayawardena, N.; Waisundara, V.Y. Evaluation of the total antioxidant capacity and antioxidant compounds of different solvent extracts of Chilgoza Pine nuts (Pinus gerardiana). J. Funct. Foods 2015, 18, 1014–1021. [Google Scholar] [CrossRef]
  49. Lee, S.J.; Lee, S.Y.; Hur, S.J.; Bae, Y., II; Jeong, C.H. Neuroprotective and antioxidant effects of Metasequoia glyptostroboides leaf extract. Curr. Top. Nutraceutical Res. 2016, 14, 67–72. [Google Scholar]
  50. Sahin Yaglioglu, A.; Eser, F. Screening of some Juniperus extracts for the phenolic compounds and their antiproliferative activities. S. Afr. J. Bot. 2017, 113, 29–33. [Google Scholar] [CrossRef]
  51. Legault, J.; Girard-Lalancette, K.; Dufour, D.; Pichette, A. Antioxidant potential of bark extracts from boreal forest conifers. Antioxidants 2013, 2, 77–89. [Google Scholar] [CrossRef]
  52. Lantto, T.A.; Colucci, M.; Závadová, V.; Hiltunen, R.; Raasmaja, A. Cytotoxicity of curcumin, resveratrol and plant extracts from basil, juniper, laurel and parsley in SH-SY5Y and CV1-P cells. Food Chem. 2009, 117, 405–411. [Google Scholar] [CrossRef]
  53. Välimaa, A.L.; Raitanen, J.E.; Tienaho, J.; Sarjala, T.; Nakayama, E.; Korpinen, R.; Mäkinen, S.; Eklund, P.; Willför, S.; Jyske, T. Enhancement of Norway spruce bark side-streams: Modification of bioactive and protective properties of stilbenoid-rich extracts by UVA-irradiation. Ind. Crops Prod. 2020, 145, 112150. [Google Scholar] [CrossRef]
  54. Raiber, S.; Schröder, G.; Schröder, J. Molecular and enzymatic characterization of two stilbene synthases from Eastern white pine (Pinus strobus) A single Arg/His difference determines the activity and the pH dependence of the enzymes. FEBS Lett. 1995, 361, 299–302. [Google Scholar] [CrossRef][Green Version]
  55. Hovelstad, H.; Leirset, I.; Oyaas, K.; Fiksdahl, A. Screening analyses of pinosylvin stilbenes, resin acids and lignans in Norwegian conifers. Molecules 2006, 11, 103–114. [Google Scholar] [CrossRef][Green Version]
  56. Francezon, N.; Meda, N.S.B.R.; Stevanovic, T. Optimization of bioactive polyphenols extraction from Picea mariana bark. Molecules 2017, 22, 2118. [Google Scholar] [CrossRef][Green Version]
  57. Latva-Mäenpää, H. Bioactive and Protective Polyphenolics From Roots and Stumps of Conifer Trees (Norway Spruce and Scots Pine); Helsingin Yliopisto: Helsinki, Finland, 2017; ISBN 9789515134653. [Google Scholar]
  58. Brodribb, T.J.; Pittermann, J.; Coomes, D.A. Elegance versus speed: Examining the competition between conifer and angiosperm trees. Int. J. Plant Sci. 2012, 173, 673–694. [Google Scholar] [CrossRef][Green Version]
  59. Larter, M. Evolution de la Résistance à la Cavitation Chez les Conifères the Evolution of Cavitation Resistance in Conifers. Ph.D. Thesis, Université de Bordeaux, Bordeaux, France, 2016. [Google Scholar]
  60. Moriguchi, Y.; Ueno, S.; Hasegawa, Y.; Tadama, T.; Watanabe, M.; Saito, R.; Hirayama, S.; Iwai, J.; Konno, Y. Marker-assisted selection of trees with MALE STERALITY 1 in Cryptomeria japonica D. Don. bioRxiv 2020, 1–10. [Google Scholar] [CrossRef]
  61. Hussein, R.A.; El-Anssary, A.A. Plants Secondary Metabolites: The Key Drivers of the Pharmacological Actions of Medicinal Plants. Herb. Med. 2019, 1, 13. [Google Scholar] [CrossRef][Green Version]
  62. Singh, B.; Sharma, R.A. Plant terpenes: Defense responses, phylogenetic analysis, regulation and clinical applications. 3 Biotech 2015, 5, 129–151. [Google Scholar] [CrossRef] [PubMed][Green Version]
  63. Porres-Martínez, M.; González-Burgos, E.; Carretero, M.E.; Pilar Gómez-Serranillos, M. In vitro neuroprotective potential of the monoterpenes α-pinene and 1,8-cineole against H2O2-induced oxidative stress in PC12 cells. Z. fur Naturforsch. Sect. C J. Biosci. 2016, 71, 191–199. [Google Scholar] [CrossRef] [PubMed]
  64. Da Silveira E Sá, R.D.C.; Andrade, L.N.; De Sousa, D.P. Sesquiterpenes from essential oils and anti-inflammatory activity. Nat. Prod. Commun. 2015, 10, 1767–1774. [Google Scholar] [CrossRef][Green Version]
  65. Dey, P.; Kundu, A.; Kumar, A.; Gupta, M.; Lee, B.M.; Bhakta, T.; Dash, S.; Kim, H.S. Analysis of Alkaloids (Indole Alkaloids, Isoquinoline Alkaloids, Tropane Alkaloids); Elsevier Inc.: Amsterdam, The Netherlands, 2020; ISBN 9780128164556. [Google Scholar]
  66. Thawabteh, A.; Juma, S.; Bader, M.; Karaman, D.; Scrano, L.; Bufo, S.A.; Karaman, R. The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens. Toxins 2019, 11, 656. [Google Scholar] [CrossRef][Green Version]
  67. Ignat, I.; Volf, I.; Popa, V.I. A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables. Food Chem. 2011, 126, 1821–1835. [Google Scholar] [CrossRef]
  68. Tanase, C.; Boz, I.; Stingu, A.; Volf, I.; Popa, V.I. Physiological and biochemical responses induced by spruce bark aqueous extract and deuterium depleted water with synergistic action in sunflower (Helianthus annuus L.) plants. Ind. Crops Prod. 2014, 60, 160–167. [Google Scholar] [CrossRef]
  69. Tanase, C.; Cosarcă, S.; Muntean, D.L. A critical review of phenolic compounds extracted from the bark of woody vascular plants and their potential biological activity. Molecules 2019, 24, 1182. [Google Scholar] [CrossRef][Green Version]
  70. El Omari, N.; Ezzahrae Guaouguaou, F.; El Menyiy, N.; Benali, T.; Aanniz, T.; Chamkhi, I.; Balahbib, A.; Taha, D.; Shariati, M.A.; Zengin, G.; et al. Phytochemical and biological activities of Pinus halepensis mill., and their ethnomedicinal use. J. Ethnopharmacol. 2021, 268, 113661. [Google Scholar] [CrossRef]
  71. Metsämuuronen, S.; Sirén, H. Bioactive phenolic compounds, metabolism and properties: A review on valuable chemical compounds in Scots pine and Norway spruce. Phytochem. Rev. 2019, 18, 623–664, ISBN 0123456789. [Google Scholar]
  72. Rodríguez-García, C.; Sánchez-Quesada, C.; Gaforio, J.J.; Gaforio, J.J. Dietary flavonoids as cancer chemopreventive agents: An updated review of human studies. Antioxidants 2019, 8, 137. [Google Scholar] [CrossRef][Green Version]
  73. Tsao, R. Chemistry and Biochemistry of Dietary Polyphenols. Nutrients 2010, 2, 1231–1246. [Google Scholar] [CrossRef]
  74. Nanda, S.; Mohanty, J.N.; Mishra, R.; Joshi, R.K. Metabolic Engineering of Phenylpropanoids in Plants. In Transgenesis and Secondary Metabolism; Springer: Berlin/Heidelberg, Germany, 2017; pp. 485–510. [Google Scholar] [CrossRef]
  75. Saleem, M.; Kim, J.; Ali, S.; Sup, Y. An update on bioactive plant lignans. Nat. Prod. Rep. 2005, 22, 696–716. [Google Scholar] [CrossRef]
  76. García-Pérez, M.E.; Royer, M.; Herbette, G.; Desjardins, Y.; Pouliot, R.; Stevanovic, T. Picea mariana bark: A new source of trans-resveratrol and other bioactive polyphenols. Food Chem. 2012, 135, 1173–1182. [Google Scholar] [CrossRef]
  77. Salminen, J.; Karonen, M. Chemical ecology of tannins and other phenolics: We need a change in approach. Br. Ecol. Soc. 2011, 25, 325–338. [Google Scholar] [CrossRef]
  78. Raitanen, J.E.; Järvenpää, E.; Korpinen, R.; Mäkinen, S.; Hellström, J.; Kilpeläinen, P.; Liimatainen, J.; Ora, A.; Tupasela, T.; Jyske, T. Tannins of conifer bark as Nordic piquancy—sustainable preservative and aroma? Molecules 2020, 25, 567. [Google Scholar] [CrossRef][Green Version]
  79. Koche, D.; Shirsat, R.; Kawale, M. An overview of major classes of phytochemicals: Their type and role in disease prevention. Hislopia J. 2016, 9, 2016. [Google Scholar]
  80. Prothmann, J.; Sun, M.; Spégel, P.; Sandahl, M.; Turner, C.; Scheuba, J.; Wronski, V.K.; Rollinger, J.M.; Grienke, U.; Santos-Buelga, C.; et al. Relationship between phenolic compounds, anthocyanins content and antioxidant activity in colored barley germplasm. J. Agric. Food Chem. 2017, 53, 1713. [Google Scholar]
  81. Matthews, S.; Mila, I.; Scalbert, A.; Donnelly, D.M.X. Extractable and non-extractable proanthocyanidins in barks. Phytochemistry 1997, 45, 405–410. [Google Scholar] [CrossRef]
  82. Koleckar, V.; Kubikova, K.; Rehakova, Z.; Kuca, K.; Jun, D.; Jahodar, L.; Opletal, L. Condensed and Hydrolysable Tannins as Antioxidants Influencing the Health. Mini-Rev. Med. Chem. 2008, 8, 436–447. [Google Scholar] [CrossRef]
  83. De Bruyne, T.; Pieters, L.; Deelstra, H.; Vlietinck, A. Condensed vegetable tannins: Biodiversity in structure and biological activities. Biochem. Syst. Ecol. 1999, 27, 445–459. [Google Scholar] [CrossRef]
  84. Scalbert, A. Antimicrobial properties of tannins. Phytochemistry 1991, 30, 3875–3883. [Google Scholar] [CrossRef]
  85. Bhangale, J.O.; Acharya, S.R. Anti-Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves. Adv. Pharmacol. Sci. 2016, 2016, 9436106. [Google Scholar] [CrossRef] [PubMed][Green Version]
  86. Brijesh, K.; Ruchi, R.; Sanjita, D.; Saumya, D.; June, A. Phytoconstituents and Therapeutic potential of Thuja occidentalis. Res. J. Pharm. Biol. Chem. Sci. 2012, 3, 354–362. [Google Scholar]
  87. Shuaib, M.; Ali, M.; Ahamad, J.; Naquvi, K.J.; Ahmad, M.I. Pharmacognosy of Pinus roxburghii: A Review. Phytochemistry 2006, 2, 262–268. [Google Scholar]
  88. Poudel, R.C.; Gao, L.M.; Möller, M.; Baral, S.R.; Uprety, Y.; Liu, J.; Li, D.Z. Yews (Taxus) along the Hindu Kush-Himalayan region: Exploring the ethnopharmacological relevance among communities of Mongol and Caucasian origins. J ethnopharmacol. 2013, 147, 190–203. [Google Scholar] [CrossRef] [PubMed]
  89. Kunwar, R.M.; Shrestha, K.P.; Bussmann, R.W. Traditional herbal medicine in Far-west Nepal: A pharmacological appraisal. J. Ethnobiol. Ethnomed. 2010, 6, 1–18. [Google Scholar] [CrossRef][Green Version]
  90. Sharma, H.; Garg, M. A review of traditional use, phytoconstituents and biological activities of Himalayan yew, Taxus wallichiana. J. Integr. Med. 2015, 13, 80–90. [Google Scholar] [CrossRef]
  91. Di Meo, S.; Reed, T.T.; Venditti, P.; Victor, V.M. Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid. Med. Cell. Longev. 2016, 2016, 1245049. [Google Scholar] [CrossRef] [PubMed]
  92. Phaniendra, A.; Jestadi, D.B.; Periyasamy, L. Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases. Indian J. Clin. Biochem. 2015, 30, 11–26. [Google Scholar] [CrossRef] [PubMed][Green Version]
  93. Kumar, H.; Bhardwaj, K.; Nepovimova, E.; Kuča, K.; Dhanjal, D.S.; Bhardwaj, S.; Bhatia, S.K.; Verma, R.; Kumar, D. Antioxidant functionalized nanoparticles: A combat against oxidative stress. Nanomaterials 2020, 10, 1334. [Google Scholar] [CrossRef]
  94. Collin, F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int. J. Mol. Sci. 2019, 20, 2407. [Google Scholar] [CrossRef][Green Version]
  95. Genestra, M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell. Signal. 2007, 19, 1807–1819. [Google Scholar] [CrossRef]
  96. Ricordi, C.; Garcia-Contreras, M.; Farnetti, S. Diet and Inflammation: Possible Effects on Immunity, Chronic Diseases, and Life Span. J. Am. Coll. Nutr. 2015, 34, 10–13. [Google Scholar] [CrossRef]
  97. Boukhenouna, S.; Wilson, M.A.; Bahmed, K.; Kosmider, B. Reactive oxygen species in chronic obstructive pulmonary disease. Oxid. Med. Cell. Longev. 2018, 2018, 5730395. [Google Scholar] [CrossRef]
  98. Packer, L.; Rimbach, G.; Virgili, F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic. Biol. Med. 1999, 27, 704–724. [Google Scholar] [CrossRef]
  99. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 2010, 4, 118–126. [Google Scholar] [CrossRef][Green Version]
  100. Iravani, S.; Zolfaghari, B. Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract. Res. Pharm. Sci. 2011, 6, 1–11. [Google Scholar]
  101. Senthilmohan, S.T.; Zhang, J.; Stanley, R.A. Effects of flavonoid extract Enzogenol with vitamin C on protein oxidation and DNA damage in older human subjects. Nutr. Res. 2003, 23, 1199–1210. [Google Scholar] [CrossRef]
  102. Azqueta, A.; Collins, A. Polyphenols and DNA damage: A mixed blessing. Nutrients 2016, 8, 785. [Google Scholar] [CrossRef]
  103. Kukreja, A.; Wadhwa, N. Therapeutic Role of Resveratrol and Piceatannol in Disease Prevention. J. Blood Disord. Transfus. 2014, 5, 9. [Google Scholar] [CrossRef][Green Version]
  104. Sharma, A.; Goyal, R.; Sharma, L. Potential biological efficacy of Pinus plant species against oxidative, inflammatory and microbial disorders. BMC Complement. Altern. Med. 2016, 16, 1–11. [Google Scholar] [CrossRef][Green Version]
  105. Azab, A.; Nassar, A.; Azab, A.N. Anti-inflammatory activity of natural products. Molecules 2016, 21, 1321. [Google Scholar] [CrossRef]
  106. Artis, D.; Spits, H. The biology of innate lymphoid cells. Nature 2015, 517, 293–301. [Google Scholar] [CrossRef]
  107. Fernandes, J.V.; Cobucci, R.N.O.; Jatobá, C.A.N.; de Medeiros Fernandes, T.A.A.; de Azevedo, J.W.V.; de Araújo, J.M.G. The Role of the Mediators of Inflammation in Cancer Development. Pathol. Oncol. Res. 2015, 21, 527–534. [Google Scholar] [CrossRef]
  108. Heppner, F.L.; Ransohoff, R.M.; Becher, B. Immune attack: The role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 2015, 16, 358–372. [Google Scholar] [CrossRef]
  109. Rock, K.L.; Rock, K.L. Innate and adaptive immune responses to cell death. Immunol. Rev. 2011, 243, 191–205. [Google Scholar] [CrossRef][Green Version]
  110. Waisman, A.; Liblau, R.S.; Becher, B. Innate and adaptive immune responses in the CNS. Lancet Neurol. 2015, 14, 945–955. [Google Scholar] [CrossRef]
  111. Vignali, D.A.A.; Kuchroo, V.K. Review IL-12 family cytokines: Immunological playmakers. Nat. Immunol. 2012, 13, 722–728. [Google Scholar] [CrossRef] [PubMed][Green Version]
  112. Montgomery, S.L.; Bowers, W.J. Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System. J. Neuroimmune Pharmacol. 2012, 7, 42–59. [Google Scholar] [CrossRef] [PubMed]
  113. Fenton, M.J. Review: Transcriptional and post-transcriptional regulation of interleukin 1 gene expression. Int. J. Immunopharm. 1992, 14, 401–411. [Google Scholar] [CrossRef]
  114. Rider, P.; Carmi, Y.; Voronov, E.; Apte, R.N. Interleukin-1α. Semin. Immunol. 2013, 25, 430–438. [Google Scholar] [CrossRef]
  115. Cha, K.-J. The Anti-Inflammatory Effects of Picea wilsonii Mast on HaCaT Cells. Korean J. Clin. Lab. Sci. 2016, 48, 365–370. [Google Scholar] [CrossRef][Green Version]
  116. Langrish, C.L.; Mckenzie, B.S.; Wilson, N.J.; Kastelein, R.A.; Cua, D.J. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol. Rev. 2004, 202, 96–105. [Google Scholar] [CrossRef]
  117. Duvallet, E.; Semerano, L.; Assier, E.; Falgarone, G.; Duvallet, E.; Semerano, L.; Assier, E.; Falgarone, G.; Duvallet, E.; Semerano, L.; et al. Interleukin-23: A key cytokine in inflammatory diseases. Ann. Med. 2011, 3890, 503–511. [Google Scholar] [CrossRef] [PubMed]
  118. Sabat, R. Cytokine & Growth Factor Reviews IL-10 family of cytokines. Cytokine Growth Factor Rev. 2010, 21, 315–324. [Google Scholar] [CrossRef]
  119. Ng, T.H.S.; Britton, G.J.; Hill, E.V.; Verhagen, J.; Burton, B.R.; Wraith, D.C. Regulation of adaptive immunity; the role of interleukin-10. Front. Immunol. 2013, 4, 1–14. [Google Scholar] [CrossRef][Green Version]
  120. Kwilasz, A.J.; Grace, P.M.; Serbedzija, P.; Maier, S.F.; Watkins, L.R. Neuropharmacology The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology 2014, 2, 55–69. [Google Scholar] [CrossRef][Green Version]
  121. Atanasov, A.G.; Waltenberger, B.; Pferschy-Wenzig, E.M.; Linder, T.; Wawrosch, C.; Uhrin, P.; Temml, V.; Wang, L.; Schwaiger, S.; Heiss, E.H.; et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015, 33, 1582–1614. [Google Scholar] [CrossRef] [PubMed][Green Version]
  122. Zhang, Q.W.; Lin, L.G.; Ye, W.C. Techniques for extraction and isolation of natural products: A comprehensive review. Chin. Med. 2018, 13, 1–26. [Google Scholar] [CrossRef] [PubMed][Green Version]
  123. Bucar, F.; Wube, A.; Schmid, M. Natural product isolation-how to get from biological material to pure compounds. Nat. Prod. Rep. 2013, 30, 525–545. [Google Scholar] [CrossRef][Green Version]
  124. Gopalasatheeskumar, K. Significant Role of Soxhlet Extraction Process in Phytochemical. Mintage J. Pharm. Med. Sci. 2018, 7, 43–47. [Google Scholar]
  125. Zhao, Q.Q.; Wang, S.F.; Li, Y.; Song, Q.Y.; Gao, K. Terpenoids with anti-inflammatory activity from Abies chensiensis. Fitoterapia 2016, 111, 87–94. [Google Scholar] [CrossRef]
  126. Stan, M.S.; Voicu, S.N.; Caruntu, S.; Nica, I.C.; Olah, N.K.; Burtescu, R.; Balta, C.; Rosu, M.; Herman, H.; Hermenean, A.; et al. Antioxidant and anti-inflammatory properties of a Thuja occidentalis mother tincture for the treatment of ulcerative colitis. Antioxidants 2019, 8, 416. [Google Scholar] [CrossRef][Green Version]
  127. Kim, D.S.; Kim, M.S.; Kang, S.W.; Sung, H.Y.; Kang, Y.H. Pine bark extract enzogenol attenuated tumor necrosis factor-α- induced endothelial cell adhesion and monocyte transmigration. J. Agric. Food Chem. 2010, 58, 7088–7095. [Google Scholar] [CrossRef]
  128. Schäfer, A.; Chovanová, Z.; Muchová, J.; Sumegová, K.; Liptáková, A.; Högger, P. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed. Pharmacother. 2005, 60, 5–9. [Google Scholar] [CrossRef] [PubMed]
  129. Latest Global Cancer Data_ Cancer Burden Rises to 18 2018. WHO. Available online: (accessed on 15 February 2021).
  130. Yan, S.H. An early history of human breast cancer: West meets East. Chin. J. Cancer 2013, 32, 475–477. [Google Scholar] [CrossRef] [PubMed]
  131. Sudhakar, A. History of Cancer, Ancient and Modern Treatment Methods. J. Cancer Sci. Ther. 2009, 01, i–iv. [Google Scholar] [CrossRef] [PubMed][Green Version]
  132. Ghosh, S.K. Giovanni Battista Morgagni (1682–1771): Father of pathologic anatomy and pioneer of modern medicine. Anat. Sci. Int. 2017, 92, 305–312. [Google Scholar] [CrossRef] [PubMed]
  133. Cancer. Available online: (accessed on 20 February 2021).
  134. Ma, X.; Wang, Z. Anticancer drug discovery in the future: An evolutionary perspective. Drug Discov. Today 2009, 14, 1136–1142. [Google Scholar] [CrossRef]
  135. Widmer, N.; Bardin, C.; Chatelut, E.; Paci, A.; Beijnen, J.; Levêque, D.; Veal, G.; Astier, A. Review of therapeutic drug monitoring of anticancer drugs part two—Targeted therapies. Eur. J. Cancer 2014, 50, 2020–2036. [Google Scholar] [CrossRef]
  136. Kuczynski, E.A.; Sargent, D.J.; Grothey, A.; Kerbel, R.S. Drug rechallenge and treatment beyond progression-implications for drug resistance. Nat. Rev. Clin. Oncol. 2013, 10, 571–587. [Google Scholar] [CrossRef] [PubMed][Green Version]
  137. Lichota, A.; Gwozdzinski, K. Anticancer activity of natural compounds from plant and marine environment. Int. J. Mol. Sci. 2018, 19, 3533. [Google Scholar] [CrossRef][Green Version]
  138. Kim, J.A.H.; Kim, D.H.; Hossain, M.A.; Kim, M.Y.; Sung, B.; Yoon, J.H.; Suh, H.; Jeong, T.C.; Chung, H.Y.; Kim, N.D. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells. Int. J. Oncol. 2014, 44, 473–480. [Google Scholar] [CrossRef][Green Version]
  139. Sharifi-Rad, J.; Ozleyen, A.; Tumer, T.B.; Adetunji, C.O.; El Omari, N.; Balahbib, A.; Taheri, Y.; Bouyahya, A.; Martorell, M.; Martins, N.; et al. Natural products and synthetic analogs as a source of antitumor drugs. Biomolecules 2019, 9, 679. [Google Scholar] [CrossRef] [PubMed]
  140. Tafrihi, M.; Imran, M.; Tufail, T.; Gondal, T.A.; Caruso, G.; Sharma, S.; Sharma, R.; Atanassova, M.; Atanassov, L.; Valere, P.; et al. The Wonderful Activities of the Genus Mentha: Not Only Antioxidant Properties. Molecules 2021, 26, 1118. [Google Scholar] [CrossRef] [PubMed]
  141. Birinci, H.; Şen, B.; Sayğılı, S.; Ölmez, E.; Uluer, E.T.; Özbilgin, K. The Effect of Pycnogenol and Paclitaxel on DNA Damage in Human Breast Cancer Cell Line. Proceedings 2017, 1, 1023. [Google Scholar] [CrossRef][Green Version]
  142. Dinić, J.; Ríos-Luci, C.; Karpaviciene, I.; Cikotiene, I.; Fernandes, M.X.; Pešić, M.; Padrón, J.M. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells. Investig. New Drugs 2020, 38, 584–598. [Google Scholar] [CrossRef] [PubMed]
  143. Binarová, P.; Tuszynski, J. Tubulin: Structure, Functions and Roles in Disease. Cells 2019, 8, 1294. [Google Scholar] [CrossRef][Green Version]
  144. Zhang, D.; Kanakkanthara, A. Beyond the paclitaxel and vinca alkaloids: Next generation of plant-derived microtubule-targeting agents with potential anticancer activity. Cancers 2020, 12, 1721. [Google Scholar] [CrossRef]
  145. Harshita; Barkat, M.A.; Beg, S.; Pottoo, F.H.; Ahmad, F.J. Nanopaclitaxel therapy: An evidence based review on the battle for next-generation formulation challenges. Nanomedicine 2019, 14, 1323–1341. [Google Scholar] [CrossRef]
  146. Ganguly, A.; Yang, H.; Cabral, F. Paclitaxel-dependent cell lines reveal a novel drug activity. Mol. Cancer Ther. 2010, 9, 2914–2923. [Google Scholar] [CrossRef][Green Version]
  147. Banerjee, S.; Das, A.; Chakraborty, P.; Suthindhiran, K.; Jayasri, M.A. Antioxidant and antimicrobial activity of Araucaria cookii and Brassaia actinophyla. Pak. J. Biol. Sci. 2014, 17, 715–719. [Google Scholar] [CrossRef][Green Version]
  148. Jain, S.; Kumar, D.; Malviya, N.; Jain, A.; Jain, S.; Jain, V. Estimation of total phenolic, tannins, and flavonoid contents and antioxidant activity of Cedrus deodara heart wood extracts. Egypt. Pharm. J. 2015, 14, 10. [Google Scholar] [CrossRef]
  149. Horiba, H.; Nakagawa, T.; Zhu, Q.; Ashour, A.; Watanabe, A.; Shimizu, K. Biological activities of extracts from different parts of cryptomeria japonica. Nat. Prod. Commun. 2016, 11, 1337–1342. [Google Scholar] [CrossRef][Green Version]
  150. Bhagat, M.; Gupta, S.; Sudan, R. In vitro Evaluation of Antioxidant Activity of Picea smithiana Growing in Bhaderwah Region of Jammu and Kashmir. Cell. Life Sci. J. 2017, 2. [Google Scholar] [CrossRef]
  151. Salhi, N.; Bouyahya, A.; El Guourrami, O.; El Jemli, M.; Bourais, I.; Zellou, A.; Cherrah, Y.; El Abbes Faouzi, M. Investigation of in vitro and in vivo antioxidant and antidiabetic activities of Pinus halepensis extracts. J. Herbmed Pharmacol. 2021, 10, 123–131. [Google Scholar] [CrossRef]
  152. Tekaday, D.; Antony, B.; Jain, S. Antimicrobial, antioxidant and phytochemical investigation of Thuja occidentalis (Arbor vitae) leave extract. GSC Biol. Pharm. Sci. 2020, 12, 108–116. [Google Scholar] [CrossRef]
  153. Milutinović, M.G.; Stanković, M.S.; Cvetković, D.M.; Topuzović, M.D.; Mihailović, V.B.; Marković, S.D. Antioxidant and anticancer properties of leaves and seed cones from European yew (Taxus baccata L.). Arch. Biol. Sci. 2015, 67, 525–534. [Google Scholar] [CrossRef]
  154. Bhat, M.A.; Ganie, S.A.; Dar, K.B.; Ali, R.; Hamid, R. In Vitro antioxidant potential and hepatoprotective activity of Taxus Wallichiana. Asian J. Pharm. Clin. Res. 2018, 11, 237–243. [Google Scholar] [CrossRef]
  155. Subba, B. Analysis of Phytochemical Constituents and Biological Activity of Taxus Wallichiana Zucc. Dolakha District of Nepal. Int. J. Appl. Sci. Biotechnol. 2018, 6, 110–114. [Google Scholar] [CrossRef]
  156. Yang, X.-W.; Zeng, H.-W.; Liu, X.-H.; Li, S.-M.; Xu, W.; Shen, Y.-H.; Zhang, C.; Zhang, W.-D. Anti-inflammatory and anti-tumour effects of Abies georgei extracts. J. Pharm. Pharmacol. 2008, 60, 937–941. [Google Scholar] [CrossRef]
  157. Nayak, S.S.; Ghosh, A.K.; Debnath, B.; Vishnoi, S.P.; Jha, T. Synergistic effect of methanol extract of Abies webbiana leaves on sleeping time induced by standard sedatives in mice and anti-inflammatory activity of extracts in rats. J. Ethnopharmacol. 2004, 93, 397–402. [Google Scholar] [CrossRef]
  158. Bisht, B.; Nainwal, P.; Saini, P. Evaluation of in vitro anti-inflammatory activity of Agathis robusta. J. Pharma. Res. 2012, 2, 1304–1306. [Google Scholar]
  159. Journal, A.I. An Indian Journal Note. Anal. Chem. 2007, 6, 4–8. [Google Scholar]
  160. Orhan, N.; Akkol, E.; Ergun, F. Evaluation of antiinflammatory and antinociceptive effects of some juniperus species growing in Turkey. Turk. J. Biol. 2012, 36, 719–726. [Google Scholar] [CrossRef]
  161. Science, A. Assessment of Anti-Inflammatory Activity of Taxus baccata Linn. Bark Extract Satyajit Dutta * G. Mariappan ** Dipankar Sarkar ** Piyali Sarkar ** Table 1: Effect of Taxus baccata (L) bark extracts on Carrageenan-induced paw edema method in rats. Anc. Sci. Life 2010, 29, 19–21. [Google Scholar]
  162. Branco, C.D.S.; De Lima, É.D.; Rodrigues, T.S.; Scheffel, T.B.; Scola, G.; Laurino, C.C.F.C.; Moura, S.; Salvador, M. Mitochondria and redox homoeostasis as chemotherapeutic targets of Araucaria angustifolia (Bert.) O. Kuntze in human larynx HEp-2 cancer cells. Chem. Biol. Interact. 2015, 231, 108–118. [Google Scholar] [CrossRef] [PubMed][Green Version]
  163. Shashi, B.; Jaswant, S.; Madhusudana, R.J.; Kumar, S.A.; Nabi, Q.G. A novel lignan composition from Cedrus deodara induces apoptosis and early nitric oxide generation in human leukemia Molt-4 and HL-60 cells. Nitric Oxide Biol. Chem. 2006, 14, 72–88. [Google Scholar] [CrossRef] [PubMed]
  164. Shi, X.; Liu, D.; Zhang, J.; Hu, P.; Shen, W.; Fan, B.; Ma, Q.; Wang, X. Extraction and purification of total flavonoids from pine needles of Cedrus deodara contribute to anti-tumor in vitro. BMC Complement. Altern. Med. 2016, 16, 1–9. [Google Scholar] [CrossRef] [PubMed][Green Version]
  165. Basu, L.R.; De, A.; Sarkar, P.; Karak, P.; Dastidar, S.G. Possibilities of developing novel potent antitumor agents from the leaves of Cryptomaria japonica. Int. J. Phytomed. 2016, 8, 404–410. [Google Scholar] [CrossRef][Green Version]
  166. Fernandez, A.; Cock, I.E. The therapeutic properties of juniperus communis L.: Antioxidant capacity, bacterial growth inhibition, anticancer activity and toxicity. Pharmacogn. J. 2016, 8, 273–280. [Google Scholar] [CrossRef][Green Version]
  167. Machana, S.; Weerapreeyakul, N.; Barusrux, S.; Nonpunya, A.; Sripanidkulchai, B.; Thitimetharoch, T. Cytotoxic and apoptotic effects of six herbal plants against the human hepatocarcinoma (HepG2) cell line. Chin. Med. 2011, 6, 2–9. [Google Scholar] [CrossRef][Green Version]
  168. MacHana, S.; Weerapreeyakul, N.; Barusrux, S.; Thumanu, K.; Tanthanuch, W. FTIR microspectroscopy discriminates anticancer action on human leukemic cells by extracts of Pinus kesiya; Cratoxylum formosum ssp. pruniflorum and melphalan. Talanta 2012, 93, 371–382. [Google Scholar] [CrossRef] [PubMed]
  169. Thu, N.B.; Trung, T.N.; Ha, D.T.; Khoi, N.M.; Hung, T.V.; Hien, T.T.; Namhui, Y.; Bae, K. Screening of Vietnamese medicinal plants for cytotoxic activity. Nat. Prod. Sci. 2010, 16, 43–49. [Google Scholar]
  170. Chattopadhyay, S.K.; Kumar, T.R.S.; Maulik, P.R.; Srivastava, S.; Garg, A.; Sharon, A.; Negi, A.S.; Khanuja, S.P.S. Absolute configuration and anticancer activity of taxiresinol and related lignans of Taxus wallichiana. Bioorg. Med. Chem. 2003, 11, 4945–4948. [Google Scholar] [CrossRef] [PubMed]
  171. Kaushik, P.; Lal Khokra, S.; Rana, A.C.; Kaushik, D. Evaluation of anticancer activity of Pinus roxburghii sarg. Against IMR-32 human neuroblastoma cancer cell line. Int. J. Pharm. Clin. Res. 2015, 7, 105–108. [Google Scholar]
  172. Jiang, P.; Zhang, Q.; Zhao, Y.; Xiong, J.; Wang, F.; Zhang, T.; Zhang, C. Extraction, Purification, and Biological Activities of Polysaccharides from Branches and Leaves of Taxus cuspidata S. Et Z. Molecules 2019, 24, 2926. [Google Scholar] [CrossRef][Green Version]
  173. Mukherjee, A.; Sikdar, S.; Bishayee, K.; Paul, A.; Ghosh, S.; Boujedaini, N.; Khuda-Bukhsh, A.R. Ethanolic extract of Thuja occidentalis blocks proliferation of A549 cells and induces apoptosis in vitro. J. Chin. Integr. Med. 2012, 10, 1451–1459. [Google Scholar] [CrossRef]
  174. Khuda-Bukhsh, A.R.; Biswas, R.; Mandal, S.K.; Dutta, S.; Bhattacharyya, S.S.; Boujedaini, N. Thujone-rich fraction of Thuja occidentalis demonstrates major anti-cancer potentials: Evidences from in vitro studies on A375 cells. Evid. Based Complement. Altern. Med. 2011, 2011, 568148. [Google Scholar] [CrossRef][Green Version]
  175. Velmurugan, B.K.; Rathinasamy, B.; Lohanathan, B.P.; Thiyagarajan, V.; Weng, C.F. Neuroprotective role of phytochemicals. Molecules 2018, 23, 2485. [Google Scholar] [CrossRef] [PubMed][Green Version]
  176. Gitler, A.D.; Dhillon, P.; Shorter, J. Neurodegenerative disease: Models, mechanisms, and a new hope. DMM Dis. Model. Mech. 2017, 10, 499–502. [Google Scholar] [CrossRef][Green Version]
  177. Venkatesan, R.; Ji, E.; Kim, S.Y. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: A comprehensive review. Biomed Res. Int. 2015, 2015, 814068. [Google Scholar] [CrossRef]
  178. Johri, A.; Beal, M.F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 2012, 342, 619–630. [Google Scholar] [CrossRef][Green Version]
  179. Yang, J.L.; Lin, Y.T.; Chuang, P.C.; Bohr, V.A.; Mattson, M.P. BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease 1. NeuroMol. Med. 2014, 16, 161–174. [Google Scholar] [CrossRef]
  180. Huang, E.J.; Reichardt, L.F. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24, 677–736. [Google Scholar] [CrossRef][Green Version]
  181. Agrawal, M.; Biswas, A.; Levy, C.E. Molecular diagnostics of neurodegenerative disorders. Front. Mol. Biosci. 2015, 2, 1–10. [Google Scholar] [CrossRef][Green Version]
  182. Olivares, D.; Deshpande, V.K.; Shi, Y.; Lahiri, D.K.; Greig, N.H.; Rogers, J.T.; Huang, X. N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease. Curr. Alzheimer Res. 2012, 9, 746–758. [Google Scholar] [CrossRef] [PubMed]
  183. Briffa, M.; Ghio, S.; Neuner, J.; Gauci, A.J.; Cacciottolo, R.; Marchal, C.; Caruana, M.; Cullin, C.; Vassallo, N.; Cauchi, R.J. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies. Neurosci. Lett. 2017, 638, 12–20. [Google Scholar] [CrossRef] [PubMed]
  184. Physiology, G.; Waczulikova, I.; Kilanczyk, E.; Bryszewska, M. The effect of Pycnogenol on the erythrocyte membrane fluidity. Gen. Physiol. Biophys. 2004, 23, 39–51. [Google Scholar]
  185. Voss, P.; Horakova, L.; Jakstadt, M.; Kiekebusch, D.; Grune, T. Ferritin oxidation and proteasomal degradation: Protection by antioxidants. Free Radic. Res. 2006, 40, 673–683. [Google Scholar] [CrossRef]
  186. Deture, M.A.; Dickson, D.W. The neuropathological diagnosis of Alzheimer’s disease. Mol. Neurodegener. 2019, 14, 1–18. [Google Scholar] [CrossRef][Green Version]
  187. Jahn, H. Memory loss in Alzheimer’s disease. Dialogues Clin. Neurosci. 2013, 15, 445–454. [Google Scholar] [PubMed]
  188. Tanvir Kabir, M.; Sahab Uddin, M.; Al Mamun, A.; Jeandet, P.; Aleya, L.; Mansouri, R.A.; Md Ashraf, G.; Mathew, B.; Bin-Jumah, M.N.; Abdel-Daim, M.M. Combination drug therapy for the management of alzheimer’s disease. Int. J. Mol. Sci. 2020, 21, 3272. [Google Scholar] [CrossRef]
  189. Durães, F.; Pinto, M.; Sousa, E. Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals 2018, 11, 44. [Google Scholar] [CrossRef][Green Version]
  190. Barbier, P.; Zejneli, O.; Martinho, M.; Lasorsa, A.; Belle, V.; Smet-Nocca, C.; Tsvetkov, P.O.; Devred, F.; Landrieu, I. Role of tau as a microtubule-associated protein: Structural and functional aspects. Front. Aging Neurosci. 2019, 10, 1–14. [Google Scholar] [CrossRef] [PubMed][Green Version]
  191. Cory, H.; Passarelli, S.; Szeto, J.; Tamez, M.; Mattei, J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Front. Nutr. 2018, 5, 1–9. [Google Scholar] [CrossRef] [PubMed][Green Version]
  192. Rensink, A.A.M.; De Waal, R.M.W.; Kremer, B.; Verbeek, M.M. Pathogenesis of cerebral amyloid angiopathy. Brain Res. Rev. 2003, 43, 207–223. [Google Scholar] [CrossRef] [PubMed]
  193. Tanaka, M.; Saito, S.; Inoue, T.; Satoh-Asahara, N.; Ihara, M. Novel therapeutic potentials of taxifolin for amyloid-β-associated neurodegenerative diseases and other diseases: Recent advances and future perspectives. Int. J. Mol. Sci. 2019, 20, 2139. [Google Scholar] [CrossRef][Green Version]
  194. Sharma, L.; Sharma, A.; Goyal, R.; Alam, J. Pinus roxburghii Sarg. Ameliorates alzheimer’s disease-type neurodegeneration and cognitive deficits caused by intracerebroventricular-streptozotocin in rats: An in vitro and in vivo study. Indian J. Pharm. Sci. 2020, 82, 861–870. [Google Scholar] [CrossRef]
  195. Hassaan, Y.; Handoussa, H.; El-Khatib, A.H.; Linscheid, M.W.; El Sayed, N.; Ayoub, N. Evaluation of plant phenolic metabolites as a source of Alzheimer’s drug leads. Biomed Res. Int. 2014, 2014, 843263. [Google Scholar] [CrossRef] [PubMed]
  196. Arbo, B.D.; André-Miral, C.; Nasre-Nasser, R.G.; Schimith, L.E.; Santos, M.G.; Costa-Silva, D.; Muccillo-Baisch, A.L.; Hort, M.A. Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease. Front. Aging Neurosci. 2020, 12, 1–15. [Google Scholar] [CrossRef] [PubMed]
  197. Ahmed, T.; Javed, S.; Javed, S.; Tariq, A.; Šamec, D.; Tejada, S.; Nabavi, S.F.; Braidy, N.; Nabavi, S.M. Resveratrol and Alzheimer’s Disease: Mechanistic Insights. Mol. Neurobiol. 2017, 54, 2622–2635. [Google Scholar] [CrossRef]
  198. Maimoona, A.; Naeem, I.; Saddiqe, Z.; Jameel, K. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J. Ethnopharmacol. 2011, 133, 261–277. [Google Scholar] [CrossRef]
  199. Peng, Q.L.; Zard, A.R.B.; Lau, B.H.S. Pycnogenol protects neurons from amyloid- b peptide-induced apoptosis. Mol. Brain Res. 2002, 104, 55–65. [Google Scholar] [CrossRef]
  200. Paarmann, K.; Prakash, S.R.; Krohn, M.; Möhle, L.; Brackhan, M.; Brüning, T.; Eiriz, I.; Pahnke, J. French maritime pine bark treatment decelerates plaque development and improves spatial memory in Alzheimer’s disease mice. Phytomedicine 2019, 57, 39–48. [Google Scholar] [CrossRef] [PubMed]
  201. Fang, C.; Lv, L.; Mao, S.; Dong, H.; Liu, B. Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment. Parkinsons Dis. 2020, 2020, 2076942. [Google Scholar] [CrossRef]
  202. Dias, V.; Junn, E.; Mouradian, M.M. The role of oxidative stress in parkinson’s disease. J. Parkinsons Dis. 2013, 3, 461–491. [Google Scholar] [CrossRef][Green Version]
  203. Chen, L.; Ding, Y.; Cagniard, B.; Van Laar, A.D.; Mortimer, A.; Chi, W.; Hastings, T.G.; Un, J.K.; Zhuang, X. Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J. Neurosci. 2008, 28, 425–433. [Google Scholar] [CrossRef][Green Version]
  204. Zoccarato, F.; Toscano, P.; Alexandre, A. Dopamine-derived dopaminochrome promotes H2O2 release at mitochondrial Complex I: Stimulation by rotenone, control by Ca2+, and relevance to Parkinson disease. J. Biol. Chem. 2005, 280, 15587–15594. [Google Scholar] [CrossRef][Green Version]
  205. Ebrahimi-Fakhari, D.; Wahlster, L.; McLean, P.J. Protein degradation pathways in Parkinson’s disease: Curse or blessing. Acta Neuropathol. 2012, 124, 153–172. [Google Scholar] [CrossRef][Green Version]
  206. Javed, H.; Nagoor Meeran, M.F.; Azimullah, S.; Adem, A.; Sadek, B.; Ojha, S.K. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson’s Disease Models. Front. Pharmacol. 2019, 9, 1555. [Google Scholar] [CrossRef][Green Version]
  207. Corona, J.C. Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder. Biomed Res. Int. 2018, 2018, 4067597. [Google Scholar] [CrossRef][Green Version]
  208. Ríos, J.L.; Onteniente, M.; Picazo, D.; Montesinos, M.C. Medicinal Plants and Natural Products as Potential Sources for Antiparkinson Drugs. Planta Med. 2016, 82, 942–951. [Google Scholar] [CrossRef][Green Version]
  209. Bais, S.; Gill, N.S.; Kumar, N. Neuroprotective Effect of Juniperus communis on Chlorpromazine Induced Parkinson Disease in Animal Model. Chin. J. Biol. 2015, 2015, 1–7. [Google Scholar] [CrossRef][Green Version]
  210. Zhang, F.; Shi, J.S.; Zhou, H.; Wilson, B.; Hong, J.S.; Gao, H.M. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol. Pharmacol. 2010, 78, 466–477, reprinted in Mol. Pharmacol. 2010, 78, 981. [Google Scholar] [CrossRef][Green Version]
  211. Fang, X.S.; Hao, J.F.; Zhou, H.Y.; Zhu, L.X.; Wang, J.H.; Song, F.Q. Pharmacological studies on the sedative-hypnotic effect of Semen Ziziphi spinosae (Suanzaoren) and Radix et Rhizoma Salviae miltiorrhizae (Danshen) extracts and the synergistic effect of their combinations. Phytomedicine 2010, 17, 75–80. [Google Scholar] [CrossRef]
  212. Akram, M.; Daniyal, M.; Munir, N.; Mohiuddin, E.; Sultana, S. Medicinal Plants Combating Against Insomnia: A Green Anti-Insomnia Approach. J. Nerv. Ment. Dis. 2019, 207, 927–935. [Google Scholar] [CrossRef]
  213. Gooneratne, N.S.; Vitiello, M.V. Sleep in Older Adults. Normative Changes, Sleep Disorders, and Treatment Options. Clin. Geriatr. Med. 2014, 30, 591–627. [Google Scholar] [CrossRef] [PubMed][Green Version]
  214. Atkin, T.; Comai, S.; Gobbi, G. Drugs for insomnia beyond benzodiazepines: Pharmacology, clinical applications, and discovery. Pharmacol. Rev. 2018, 70, 197–245. [Google Scholar] [CrossRef]
  215. Sateia, M.J.; Buysse, D.J.; Krystal, A.D.; Neubauer, D.N. Adverse effects of hypnotic medications. J. Clin. Sleep Med. 2017, 13, 839. [Google Scholar] [CrossRef] [PubMed][Green Version]
  216. Woo, J.; Yang, H.; Yoon, M.; Gadhe, C.G.; Pae, A.N.; Cho, S.; Justin Lee, C. 3-Carene, a phytoncide from pine tree has a sleep-enhancing effect by targeting the GABAA-benzodiazepine receptors. Exp. Neurobiol. 2019, 28, 593–601. [Google Scholar] [CrossRef][Green Version]
  217. Arumugam, G.; Manjula, P.; Paari, N. A review: Anti diabetic medicinal plants used for diabetes mellitus. J. Acute Dis. 2013, 2, 196–200. [Google Scholar] [CrossRef][Green Version]
  218. Salehi, B.; Ata, A.; Kumar, N.V.A.; Sharopov, F.; Ramírez-Alarcón, K.; Ruiz-Ortega, A.; Ayatollahi, S.A.; Fokou, P.V.T.; Kobarfard, F.; Zakaria, Z.A.; et al. Antidiabetic potential of medicinal plants and their active components. Biomolecules 2019, 9, 551, ISBN 5641266167. [Google Scholar] [CrossRef] [PubMed][Green Version]
  219. Upendra Rao, M.; Sreenivasulu, M.; Chengaiah, B.; Jaganmohan Reddy, K.; Madhusudhana Chetty, C. Herbal medicines for diabetes mellitus: A review. Int. J. PharmTech Res. 2010, 2, 1883–1892. [Google Scholar]
  220. Warren, R.E. The stepwise approach to the management of type 2 diabetes. Diabetes Res. Clin. Pract. 2004, 65, S3. [Google Scholar] [CrossRef] [PubMed]
  221. Wadkar, K.A.; Magdum, C.S.; Patil, S.S.; Naikwade, N.S. Anti-diabetic potential and Indian medicinal plants. J. Herbmed Toxicol. 2014, 2, 45–50. [Google Scholar]
  222. Afrisham, R.; Aberomand, M.; Ghaffari, M.A.; Siahpoosh, A.; Jamalan, M. Inhibitory Effect of Heracleum persicum and Ziziphus jujuba on Activity of Alpha-Amylase. J. Bot. 2015, 2015, 824683. [Google Scholar] [CrossRef][Green Version]
  223. Jeong, S.O.; Son, Y.; Lee, J.H.; Cheong, Y.K.; Park, S.H.; Chung, H.T.; Pae, H.O. Resveratrol analog piceatannol restores the palmitic acid-induced impairment of insulin signaling and production of endothelial nitric oxide via activation of anti-inflammatory and antioxidative heme oxygenase-1 in human endothelial cells. Mol. Med. Rep. 2015, 12, 937–944. [Google Scholar] [CrossRef] [PubMed][Green Version]
  224. Vallianou, N.G.; Evangelopoulos, A.; Kazazis, C. Resveratrol and diabetes. Rev. Diabet. Stud. 2013, 10, 236–242. [Google Scholar] [CrossRef] [PubMed][Green Version]
  225. Szkudelski, T.; Szkudelska, K. Resveratrol and diabetes: From animal to human studies. Biochim. Biophys. Acta Mol. Basis Dis. 2015, 1852, 1145–1154. [Google Scholar] [CrossRef][Green Version]
  226. Bagul, P.K.; Banerjee, S.K. Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges. Curr. Mol. Med. 2015, 15, 312–330. [Google Scholar] [CrossRef]
  227. Sciences, D. The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications. Neurol. Med. Chir. 2016, 56, 205–220. [Google Scholar] [CrossRef][Green Version]
  228. Kaushik, D.; Kumar, A.; Kaushik, P.; Rana, A.C. Anticonvulsant activity of alcoholic extract of bark of Pinus roxburghii Sarg. J. Chin. Integr. Med. 2012, 10, 1056–1060. [Google Scholar] [CrossRef]
  229. Dhayabaran, D.; Florance, E.J.; Nandakumar, K.; Shanmugarathinam, A.; Puratchikody, A. Anticonvulsant activity of fraction isolated from ethanolic extract of heartwood of Cedrus deodara. J. Nat. Med. 2014, 68, 310–315. [Google Scholar] [CrossRef] [PubMed]
  230. Wang, Y.W.; Yang, C.T.; Gong, C.L.; Chen, Y.H.; Chen, Y.W.; Wu, K.C.; Cheng, T.H.; Kuo, Y.H.; Chen, Y.F.; Leung, Y.M. Inhibition of voltage-gated Na+ channels by hinokiol in neuronal cells. Pharmacol. Rep. 2015, 67, 1049–1054. [Google Scholar] [CrossRef] [PubMed]
  231. Vasconcelos, S.M.M.; Lima, S.R.; Soares, P.M.; Assreuy, A.M.S.; de Sousa, F.C.F.; Lobato, R.d.F.G.; Vasconcelos, G.S.; Santi-Gadelha, T.; Bezerra, E.H.S.; Cavada, B.S.; et al. Central action of Araucaria angustifolia seed lectin in mice. Epilepsy Behav. 2009, 15, 291–293. [Google Scholar] [CrossRef] [PubMed]
  232. Hijazi, M.A.; El-Mallah, A.; Aboul-Ela, M.; Ellakany, A. Evaluation of Analgesic Activity of Papaver libanoticum Extract in Mice: Involvement of Opioids Receptors. Evid. Based Complement. Altern. Med. 2017, 2017, 8935085. [Google Scholar] [CrossRef] [PubMed]
  233. Deng, J.S.; Chi, C.S.; Huang, S.S.; Shie, P.H.; Lin, T.H.; Huang, G.J. Antioxidant, analgesic, and anti-inflammatory activities of the ethanolic extracts of Taxillus liquidambaricola. J. Ethnopharmacol. 2011, 137, 1161–1171. [Google Scholar] [CrossRef] [PubMed]
  234. Deshmukh, A.; Morankar, P.G.; Kumbhare, M.R. Review on Analgesic Activity and Determination Methods. Pharmtechmedica 2014, 3, 425–428. [Google Scholar]
  235. Machado, F.D.; Kuo, J.; Ongaratti, B.R.; Medeiros, N.D.; Salvador, M.; Dani, C.; Funchal, C. Antioxidant and neuroprotective potential of extract of Brazilian pine Araucaria angustifolia bracts against oxidative stress induced by sodium azide in hippocampus. Integr. Pharmacol. Toxicol. Genotoxicol. 2015, 1, 16–20. [Google Scholar]
  236. Thiago, C.; Patrícia de Brum, V.; Patrícia Gomes da, S.; Marines de Avila, H.; Graziele Daiane, S.; Michele Stach, C.; Antônio Batista, P.; Sidnei, M.; Andreas Sebastian, M.; Chariston André Dal, B. Mechanism of the Entomotoxic Activity Induced by Araucaria Angustifolia Methanolic Extract in Nauphoeta Cinerea Lobster Cockroaches. J. Bot. Res. 2017, 1, 38–49. [Google Scholar] [CrossRef]
  237. Zhao, Z.; Dong, Z.; Ming, J.; Liu, Y. Cedrin identified from Cedrus deodara (Roxb.) G. Don protects PC12 cells against neurotoxicity. Nat. Prod. Res. 2018, 6419, 1455–1458. [Google Scholar] [CrossRef]
  238. Lee, J.S.; Kim, H.G.; Lee, H.W.; Han, J.M.; Lee, S.K.; Kim, D.W.; Saravanakumar, A.; Son, C.G. Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model. Sci. Rep. 2015, 5, 1–10. [Google Scholar] [CrossRef][Green Version]
  239. Lee, J.S.; Kim, H.G.; Lee, H.W.; Kim, W.Y.; Ahn, Y.C.; Son, C.G. Pine needle extract prevents hippocampal memory impairment in acute restraint stress mouse model. J. Ethnopharmacol. 2017, 207, 226–236. [Google Scholar] [CrossRef] [PubMed]
  240. Forouzanfar, F.; Ghorbani, A.; Hosseini, M. Hydroalcoholic extract of needles of Pinus eldarica enhances pentobarbital-induced sleep: Possible involvement of GABAergic system. Avicenna J. Phytomed. 2016, 6, 449. [Google Scholar] [PubMed]
  241. Wang, C.; He, L.; Yan, M. Effects of polyprenols from pine needles of Pinus massoniana on ameliorating cognitive impairment in a D -galactose-induced mouse model. Age 2014, 36, 9676. [Google Scholar] [CrossRef][Green Version]
  242. Khan, M.M.; Kempuraj, D.; Thangavel, R.; Zaheer, A. Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. Neurochem. Int. 2013, 62, 379–388. [Google Scholar] [CrossRef][Green Version]
  243. Kabra, A.; Baghel, U.S.; Hano, C.; Martins, N.; Khalid, M.; Sharma, R. Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease. J. Ayurveda Integr. Med. 2020, 11, 448–454. [Google Scholar] [CrossRef]
  244. Lokesh, D.; Amitabha, D.; Sachin, A.; Avijeet, J. Neuropharmacological Exploration of Thuja Occidentalis Linn. Int. Res. J. Pharm. 2011, 2, 143–148. [Google Scholar]
  245. Lee, S.; Choi, C.; Kim, J.; Lim, S.; Jung, H. The Antioxidant Activities and Neuroprotective Effects of Hot Water Extracts from Torreyae Semen. Korea J. Herbol. 2017, 32, 41–48. [Google Scholar]
  246. Pradeep Kumar, C.; Lokesh, T.; Gobinath, M.; Kumar, B.; Saravanan, D. Anti-diabetic and anti-hyperlipidemic activities of glucomannan isolated from Araucaria cunninghamii seeds. J. Chem. Pharm. Sci. 2013, 6, 204–209. [Google Scholar]
  247. Jain, S.; Jain, A.; Malviya, N.; Kumar, D.; Jain, V.; Jain, S. Antidiabetic Activity of Cedrus deodara Aqueous Extract and Its Relationship with Its Antioxidant Properties. J. Pharm. Sci. Pharmacol. 2015, 1, 187–194. [Google Scholar] [CrossRef]
  248. De Medina, F.S.; Gamez, M.J.; Jimenez, I.; Jimenez, J.; Osuna, J.I.; Zarzuelo, A. Hypoglycemic activity of juniper “berries”. Planta Med. 1994, 60, 197–200. [Google Scholar] [CrossRef]
  249. Esmail Al-Snafi, A.; Majid, W.J.; Ali Talab, T.; Author, C. Medicinal Plants with Antidiabetic Effects-An Overview (Part 1) Clinically tested medicinal plants View project Medicinal plants with antimicrobial effects View project Medicinal Plants with Antidiabetic Effects-An Overview (Part 1). IOSR J. Pharm. 2019, 9, 9–46. [Google Scholar]
  250. Orhan, N.; Aslan, M.; Demirci, B.; Ergun, F. A bioactivity guided study on the antidiabetic activity of Juniperus oxycedrus subsp. oxycedrus L. leaves. J. Ethnopharmacol. 2012, 140, 409–415. [Google Scholar] [CrossRef] [PubMed]
  251. Zulfqar, F.; Akhtar, M.F.; Saleem, A.; Akhtar, B.; Sharif, A.; Saleem, U. Chemical characterization, antioxidant evaluation, and antidiabetic potential of Pinus gerardiana (Pine nuts) extracts. J. Food Biochem. 2020, 44, 1–12. [Google Scholar] [CrossRef]
  252. Liu, X.; Wei, J.; Tan, F.; Zhou, S.; Würthwein, G.; Rohdewald, P. Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II. Life Sci. 2004, 75, 2505–2513. [Google Scholar] [CrossRef]
  253. Kaushik, P.; Khokra, D. Evaluation of Antidiabetic Potential of Pinus roxburghii Bark Extract in Alloxan Induced Diabetic Rats. J. Pharmacogn. Nat. Prod. 2016, 1, 1–5. [Google Scholar] [CrossRef][Green Version]
  254. Haman, N.; Morozova, K.; Tonon, G.; Scampicchio, M.; Ferrentino, G. Antimicrobial effect of Picea abies extracts on E. coli growth. Molecules 2019, 24, 4053. [Google Scholar] [CrossRef][Green Version]
  255. Dorman, H.J.D.; Deans, S.G. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J. Appl. Microbiol. 2000, 88, 308–316. [Google Scholar] [CrossRef]
  256. Céspedes, C.L.; Avila, J.G.; García, A.M.; Becerra, J.; Flores, C.; Aqueveque, P.; Bittner, M.; Hoeneisen, M.; Martinez, M.; Silva, M. Antifungal and antibacterial activities of Araucaria araucana (Mol.) K. Koch heartwood lignans. Z. fur Naturforsch. Sect. C J. Biosci. 2006, 61, 35–43. [Google Scholar] [CrossRef]
  257. Hedenström, E.; Fagerlund Edfeldt, A.; Edman, M.; Jonsson, B.G. Resveratrol, piceatannol, and isorhapontigenin from Norway spruce (Picea abies) debarking wastewater as inhibitors on the growth of nine species of wood-decaying fungi. Wood Sci. Technol. 2016, 50, 617–629. [Google Scholar] [CrossRef]
  258. De Souza Wuillda, A.C.J.; Martins, R.C.C.; Costa, F.D.N. Larvicidal activity of secondary plant metabolites in aedes aegypti control: An overview of the previous 6 years. Nat. Prod. Commun. 2019, 14, 1934578X19862893. [Google Scholar] [CrossRef][Green Version]
  259. Hales, S.; De Wet, N.; Maindonald, J.; Woodward, A. Potential effect of population and climate changes on global distribution of dengue fever: An empirical model. Lancet 2002, 360, 830–834. [Google Scholar] [CrossRef]
  260. Wondimu, E.; Hirpasa, T.; Tadele, A. Larvicidal activity of Juniperus procera extract against anopheles mosquito in in vitro, North Western Ethiopia. J. Med. Plants Res. 2020, 14, 445–450. [Google Scholar] [CrossRef]
  261. Nayak, J.B.; Mohan, B. Larvicidal activity of Rauvolfia serpentina L. fruits against Aedes aegypti Mosquito larvae. Int. Res. J. Biol. Sci. 2015, 4, 54–56. [Google Scholar]
  262. Phambala, K.; Tembo, Y.; Kasambala, T.; Kabambe, V.H.; Stevenson, P.C.; Belmain, S.R. Bioactivity of common pesticidal plants on fall Armyworm Larvae (Spodoptera frugiperda). Plants 2020, 9, 112. [Google Scholar] [CrossRef][Green Version]
  263. Sharma, P.; Mohan, L.; Srivastava, C.N. Larvicidal potential of Nerium indicum and Thuja oriertelis extracts against malaria and Japanese encephalitis vector. J. Environ. Biol. 2005, 26, 657–660. [Google Scholar]
  264. Hasaballah, A.; Shehata, A.; Fouda, M.; Hassan, M.; Gad, M. The Biological Activity of Cupressus sempervirens Extracts against Musca domestica. Asian J. Biol. 2018, 5, 1–12. [Google Scholar] [CrossRef]
  265. Setiawan, S.; Koerniasari, K.; Ngadino, N.; Sudjarwo, S.A. Bioinsecticide effect of Pinus merkusii tree bark extract on aedes aegypti larvae. J. Young Pharm. 2017, 9, 127–130. [Google Scholar] [CrossRef][Green Version]
  266. Tang, Y.L.; Chan, S.W. A review of the pharmacological effects of piceatannol on cardiovascular diseases. Phyther. Res. 2014, 28, 1581–1588. [Google Scholar] [CrossRef]
  267. Rohdewald, P. Pleiotropic Effects of French Maritime Pine Bark Extract to Promote Healthy Aging. Rejuvenation Res. 2019, 22, 210–217. [Google Scholar] [CrossRef]
  268. Markus, M.A.; Morris, B.J. Resveratrol in prevention and treatment of common clinical conditions of aging. Clin. Interv. Aging 2008, 3, 331–339. [Google Scholar] [CrossRef] [PubMed]
  269. Shaito, A.; Posadino, A.M.; Younes, N.; Hasan, H.; Halabi, S.; Alhababi, D.; Al-Mohannadi, A.; Abdel-Rahman, W.M.; Eid, A.H.; Nasrallah, G.K.; et al. Potential adverse effects of resveratrol: A literature review. Int. J. Mol. Sci. 2020, 21, 2084. [Google Scholar] [CrossRef][Green Version]
  270. Kee, H.J.; Park, S.; Kang, W.; Lim, K.S.; Kim, J.H.; Ahn, Y.; Jeong, M.H. Piceatannol attenuates cardiac hypertrophy in an animal model through regulation of the expression and binding of the transcription factor GATA binding factor 6. FEBS Lett. 2014, 588, 1529–1536. [Google Scholar] [CrossRef] [PubMed][Green Version]
  271. Malekahmadi, M.; Moradi Moghaddam, O.; Islam, S.M.S.; Tanha, K.; Nematy, M.; Pahlavani, N.; Firouzi, S.; Zali, M.R.; Norouzy, A. Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol. Trials 2020, 21, 1–10. [Google Scholar] [CrossRef][Green Version]
  272. Shand, B.; Strey, C.; Scott, R.; Morrison, Z.; Gieseg, S. Pilot study on the clinical effects of dietary supplementation with Enzogenol, a flavonoid extract of pine bark and vitamin C. Phyther. Res. 2003, 17, 490–494. [Google Scholar] [CrossRef]
  273. Divvela, H.N.D.; Duppala, L.; Kolapalli, V.R.M. Isolation and acute oral toxicity studies of Araucaria heterophylla novel natural polysaccharide gum in albino mice. World J. Pharm. Pharm. Sci. 2016, 5, 702–711. [Google Scholar] [CrossRef]
  274. Grobosch, T.; Schwarze, B.; Stoecklein, D.; Binscheck, T. Fatal poisoning with Taxus baccata. quantification of paclitaxel (taxol A), 10-deacetyltaxol, baccatin III, 10-deacetylbaccatin III, cephalomannine (taxol B), and 3,5-dimethoxyphenol in body fluids by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2012, 36, 36–43. [Google Scholar] [CrossRef]
Figure 1. Global distribution of all conifers [11].
Figure 1. Global distribution of all conifers [11].
Molecules 26 03005 g001
Figure 2. Structures of phytochemical compounds present in different conifer spp.
Figure 2. Structures of phytochemical compounds present in different conifer spp.
Molecules 26 03005 g002aMolecules 26 03005 g002bMolecules 26 03005 g002c
Figure 3. Action mechanism of conifers’ phytochemical compounds in oxidative stress, apoptosis, and neurodegenerative diseases. The phytochemicals’ multi-target effects in the brain include mitochondrial protection, anti-aggregation, anti-oxidant, anti-apoptotic and anti-inflammatory activity.
Figure 3. Action mechanism of conifers’ phytochemical compounds in oxidative stress, apoptosis, and neurodegenerative diseases. The phytochemicals’ multi-target effects in the brain include mitochondrial protection, anti-aggregation, anti-oxidant, anti-apoptotic and anti-inflammatory activity.
Molecules 26 03005 g003
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bhardwaj, K.; Silva, A.S.; Atanassova, M.; Sharma, R.; Nepovimova, E.; Musilek, K.; Sharma, R.; Alghuthaymi, M.A.; Dhanjal, D.S.; Nicoletti, M.; Sharma, B.; Upadhyay, N.K.; Cruz-Martins, N.; Bhardwaj, P.; Kuča, K. Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential. Molecules 2021, 26, 3005.

AMA Style

Bhardwaj K, Silva AS, Atanassova M, Sharma R, Nepovimova E, Musilek K, Sharma R, Alghuthaymi MA, Dhanjal DS, Nicoletti M, Sharma B, Upadhyay NK, Cruz-Martins N, Bhardwaj P, Kuča K. Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential. Molecules. 2021; 26(10):3005.

Chicago/Turabian Style

Bhardwaj, Kanchan, Ana Sanches Silva, Maria Atanassova, Rohit Sharma, Eugenie Nepovimova, Kamil Musilek, Ruchi Sharma, Mousa A. Alghuthaymi, Daljeet Singh Dhanjal, Marcello Nicoletti, Bechan Sharma, Navneet Kumar Upadhyay, Natália Cruz-Martins, Prerna Bhardwaj, and Kamil Kuča. 2021. "Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential" Molecules 26, no. 10: 3005.

Article Metrics

Back to TopTop